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Abstract
Cardiac sodium (Na+) MRI has the potential to unveil relationships between chronic kidney
disease (CKD) and cardiovascular disease (CVD). Unfortunately, this modality requires
many technical adaptations before it’s possible to extract and compare image data between
individuals. This study investigated whether cardiac electrocardiogram (ECG) gating could
improve image quality, and whether a uniform phantom could increase signal uniformity if a
surface coil is used to acquire the image. Healthy participants were imaged with a custombuilt surface coil and 3.0-T MR system. Cardiac gated images presented with a decreased
signal-to-noise ratio (SNR), but intensity correction significantly increased image signal
uniformity. Future studies using cardiac Na+ MRI with a surface coil should consider
implementing signal intensity correction but should recognize that cardiac gating reduces
image quality unless scan time is increased.

Keywords
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Summary for Lay Audience
Introduction: Patients with damaged kidneys are also often found to suffer from heart
conditions. Since damaged kidneys can’t adequately excrete excess sodium in the body, it
would be beneficial to image sodium in the heart tissue of kidney disease patients and
compare this to their heart function. This can be done using sodium MRI, but the low
concentration of sodium in tissue is a challenging problem and imaging hardware and
techniques must first be optimized. In this study, we set out to improve sodium MR image
quality by removing the motion of the heart during imaging and correcting for the nonuniform image signal created by the custom-made imaging hardware.
Methods: We imaged the hearts of four healthy individuals with sodium MRI in each part of
this study. In the first part of this study, each participant’s heart was imaged with and without
heart motion. These images were then compared to assess image quality. In the second part
of the study, a large bin with vials containing different concentrations of saline solution were
imaged, along with large bin of uniform saline concentration. The image of the vials was
divided by the image of the bin to correct for the signal intensity uniformity. Vial images
before and after correction were compared to determine whether the intensity was corrected.
This correction was then applied to each participant’s heart images as well.
Results: Removing heart motion during sodium imaging was not found to increase image
quality but correcting the signal intensity uniformity of the images was found to be possible.
Conclusions: Technical adaptions must be implemented when imaging human hearts with
sodium MRI. Removing heart motion is not necessary for quality images. However, signal
intensity correction is necessary if quantitative measurements from image data are to be
extracted and compared between participants. Dividing a heart sodium image by an image of
a uniform saline solution can correct for the inherent signal intensity non-uniformity. Future
studies may include using these technical adaptations to image the hearts of patients with
kidney disease with sodium MRI to determine whether sodium build-up in heart tissue
correlates with heart complications.
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Chapter 1

1

Introduction

This thesis assesses the utility of technical adaptations for cardiac sodium (Na+) magnetic
resonance imaging (MRI). These technical adaptations include electrocardiogram (ECG)
gating and the correction of image signal intensity non-uniformity. This introductory
chapter provides background information related to biological Na+, chronic kidney
disease, hemodialysis, cardiovascular disease risk, proton (H+) MRI and Na+ MRI. The
following sections of this chapter will provide the introduction and motivation for this
thesis research project.

1.1

Motivation and Overview

CKD is defined as structural or functional damage to the kidneys that has persisted for
longer than 3 months. This damage reduces their ability to filter the blood, which
otherwise maintains water, ion, and pH balance and removes toxins. CKD is a prominent
health issue worldwide, with the global prevalence recently recorded to be 9.1%.1 It is
also well established that patients with CKD are at an increased risk for developing
cardiovascular disease (CVD). Although it is apparent that CKD and CVD are closely
related, the direct link between these diseases remains unclear. Many studies have
confirmed the presence of diffuse myocardial interstitial fibrosis using spin-lattice
relaxation (T1) mapping of heart tissue and demonstrated left ventricular hypertrophy
(LVH) in the hearts of CKD patients.2–6 Studies have also shown CKD patients to have
Na+ accumulation in different regions of their bodies, as their kidneys have impaired
excretion of sodium.7 Since Na+ is a ion involved in many important biological processes,
especially in the myocardium, it is possible that a Na+ imbalance may be related to
cardiac abnormalities in CKD patients. Na+ MRI is a valuable non-invasive imaging
modality that can evaluate the Na+ content of tissues including the myocardium.8 It would
be beneficial to use Na+ MRI for investigating the correlations between myocardial
fibrosis, left ventricular (LV) dysfunction, and myocardial Na+ content in CKD patients.
Investigating the potential build-up of Na+ in the myocardium is important, as other
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studies have found instances of Na+ accumulation to influence many signal pathways and
correlate with several adverse biological processes, such as ischemia, inflammation, and
fibrosis.9–11 However, before it’s possible to use cardiac Na+ MRI to extract and compare
image data between individuals, many technical adaptations must be addressed.
Specifically, should ECG gating be implemented to remove cardiac motion during
imaging? And is the signal intensity nonuniformity created by surface coil imaging able
to be corrected for?
In this thesis, the hearts of healthy participants are imaged using cardiac Na+ MRI to
determine the technical adaptations needed for imaging before applying the modality to a
future patient study. Chapter 1 provides an outline of the background information,
techniques used, and motivation for this thesis. Chapter 2 evaluates the effects of ECG
gating on Na+ MR image quality using a 3-Tesla (T) clinical scanner. Chapter 3 evaluates
the effectiveness of an intensity correction method that uses Na+ phantom images by first
testing it on Na+ calibration images before applying it to the cardiac images themselves.

1.2

The Kidney

This section provides an overview of the anatomy and physiology of the kidneys while
extending these concepts to states of disease.

1.2.1

Kidney Anatomy

The kidneys are two bean-shaped organs located in the middle-back portion of the
abdominal cavity and lay on either side of the spine. They are located between the
membranes that line the abdomen and the bones and muscles of the back. This
positioning is named retroperitoneal. The kidneys are connected to the blood stream
through the renal artery and vein, and they are connected to the bladder through the
ureter. These structures are attached to the kidneys at the inner concave side. The kidneys
themselves consist of an outer layer named the cortex and an inner layer named the
medulla. Figure 1.1 presents a labelled diagram of the kidney anatomy.
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Figure 1.1: Labelled diagram of the human kidney, including the cortex, medulla,
renal artery, renal vein, and ureter. Created with BioRender.com.
The functional units of the kidneys are located in the cortex and are referred to as
nephrons. The nephron consists of two main parts: the renal corpuscle and the renal
tubule (Figure 1.2). Within the renal corpuscle is a capillary bed known as the glomerulus
which is surrounded by a structure called Bowman’s capsule. The renal tubule is a long
tubular structure that can be broken down into four main sections: the proximal tubules,
loop of Henle, distal convoluted tubule, and collecting duct. There are approximately 1.2
million nephrons in each kidney that are surrounded by networks of blood vessels.12
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Figure 1.2: Labelled diagram of the nephron, including the renal corpuscle: the
glomerulus and Bowman’s capsule, and the renal tubule: the proximal tubule, loop
of Henle, distal convoluted tubule, and collecting duct. Created with
BioRender.com.

1.2.2

Kidney Physiology

The kidneys have many essential functions including controlling acid-base and water
balances, maintaining electrolyte balance, removing waste and toxins, controlling blood
pressure, and producing hormones. These processes occur as blood enters the kidneys
through the renal artery and is filtered by the nephrons. The waste that remains in the
nephrons at the end of filtration is sent through the ureter to be stored in the bladder as
urine, and the filtered blood exits the kidneys through the renal vein.
Blood initially enters the nephron through the afferent arteriole and into the glomerulus
where filtration occurs. Almost all components of the blood besides red and white blood
cells and proteins are filtered into Bowman’s capsule to produce a fluid called the
ultrafiltrate. The components of the blood that remain in the glomerulus exit through the
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efferent arteriole and remain in the blood vessels surrounding the nephron. The filtrate in
Bowman’s capsule proceeds through the renal tubule where water, ions, glucose, and
amino acids are reabsorbed from the filtrate to surrounding capillaries. Secretion of
molecules from surrounding capillaries into the filtrate in the tubule can also occur. At
the end of the collecting duct is a concentrated filtrate of wastes also known as urine. The
amount of solute excreted by the body in urine depends on the amount filtered into
Bowman’s capsule, the amount reabsorbed into surrounding capillaries, and the amount
secreted into the tubule by these capillaries.
Kidney function can be measured by the amount of fluid/solutes that are filtered per unit
time from the glomerulus into Bowman’s capsule. This is known as the glomerular
filtration rate (GFR). GFR cannot easily be directly measured in an individual and
therefore an estimated glomerular filtration rate (eGFR) is used to measure kidney
function instead. A substance called creatinine is used to measure eGFR because it is a
waste substance that is almost fully excreted and therefore gives a convenient indication
of glomerular filtration. To measure eGFR the creatinine concentration in blood is
needed. A normal eGFR is usually around 125 mL/min, but can differ depending on age,
sex, and body size.12

1.2.3

Sodium (Na+) Handling by the Kidney

Sodium can be excreted from the body through sweat, feces, and urine. Of particular
interest to this thesis, the kidney is the main excretory mechanism for biological Na+.13
Although in most healthy individuals, less than one percent of the amount of Na+ that was
initially filtered into Bowman’s capsule is excreted from the body in the urine. The
kidney is able to alter the excretion of Na+ in order to maintain Na+ homeostasis.
Along the length of the renal tubule, there are many transporters and channels that assist
in the reabsorption of Na+ into the surrounding capillaries, and some of them are
regulated by hormones. Some channels that reabsorb Na+ in the proximal tubule are
regulated by a hormone called angiotensin II and some in the collecting duct are
regulated by aldosterone. Angiotensin II and aldosterone are hormones that are a part of
the renin-angiotensin aldosterone system (RAAS). The RAAS is a multi-step system that
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regulates Na+ balance and therefore blood pressure. A hormone called renin is released
by the kidneys when low blood pressure or low levels of Na+ in the blood are detected.
Renin catalyzes one of the steps in the processes of angiotensin II formation. Angiotensin
II acts on channels in the proximal tubule to increase Na+ reabsorption. It also acts on the
adrenal glands to stimulate production of aldosterone, which act on channels in the
collecting duct to increase Na+ reabsorption. The result is increased Na+ retention and
therefore increased blood pressure.
Atrial natriuretic peptide (ANP) is another hormone that regulates Na+ excretion by the
kidneys. When there are high concentrations of Na+ in the blood, high extracellular
volume, and high blood pressure, the walls of the cardiac atria distend and release ANP
into the bloodstream. ANP goes to inhibit aldosterone release from the adrenal glands and
dilates the afferent arteriole to increase GFR. This process decreases the reabsorption of
Na+ in the collecting duct and increases the amount of Na+ filtered into Bowman’s
capsule. The result is increased Na+ excretion by the kidneys.
Another important process by which the kidneys regulate Na+ balance is
tubuloglomerular feedback. Through this process, the GFR is regulated based on the
contents of the ultrafiltrate. Specialized cells detect the amount of Na+ in the renal tubule
and constrict the afferent arteriole if the Na+ levels are too high. This reduces the GFR
and therefore reduces the amount of Na+ filtered into Bowman’s capsule.

1.2.4

Chronic Kidney Disease (CKD)

In a 2017 study, there was a 9.1% global prevalence of all-stage CKD.1 CKD is defined
as kidney structural or functional damage for more than three months. Certain conditions
cause kidney function to decline, with hypertension and diabetes being the two most
common causes of CKD. There are five stages of CKD based on the patient’s eGFR
which is expressed in relation to body surface area. Table 1.1 gives an overview of the
five stages of CKD.14 Overall, CKD is a collective term for any damage to the kidneys
that results in decreased GFR, and is therefore not specific. CKD often occurs alongside
various other health complications and is a major risk factor of morbidity and mortality.
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Table 1.1: The Five Stages of CKD with eGFR Values
eGFR (mL/min/1.73m2)

Kidney Function

Stage 1

 90

Normal or high

Stage 2

60-89

Mildly decreased

Stage 3

30-59

Moderately decreased

Stage 4

15-29

Severely decreased

Stage 5

 15 (or on hemodialysis)

Kidney failure

1.2.4.1

Hemodialysis (HD)

Patients with CKD that have an eGFR of  15 mL/min/1.73m2 or lose more than 85-90%
of their kidney function are normally placed on dialysis therapy. The most common type
of dialysis therapy is hemodialysis (HD). The purpose of this treatment is to mimic a
fully functioning kidney by filtering the blood and restoring the intracellular and
extracellular fluid environment. During HD, the patient’s blood is pumped outside of the
body and through an artificial kidney machine or dialyzer before returning back to the
patient. The dialyzer is a tube that contains a bundle of very thin hollow fibres, where the
fibre material itself is a semi-permeable membrane. Blood flows through the center of the
hollow fibres in one direction, and the dialysate fluid surrounds the fibres and flows in
the opposite direction (Figure 1.3). The dialysate is a solution of water, electrolytes, and
salts. Its composition dictates the filtration of the blood and can be modified depending
on clinical need. As the blood flows through the dialyzer, waste and excess fluids pass
through the semi-permeable membrane and are removed by the dialysate fluid. This
occurs through the diffusion of molecules from an area of higher to lower concentration,
and ultrafiltration of fluids from areas of higher to lower pressure.15
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Figure 1.3: Labelled diagram of a dialyzer, indicating the direction of blood flow
through the hollow fibres and the direction dialysate fluid flow. Created with
BioRender.com.
Patients on HD have an additional mechanism of Na+ excretion, which is through dialysis
due to their minimal kidney function. During dialysis, most of the Na+ is removed by
ultrafiltration rather than diffusion.16 Therefore, the amount of Na+ removed depends
mostly on the amount of fluid removed, with diffusion fine tuning the Na+ removal.
Most commonly, patients on HD receive treatment three times a week for about four
hours per session. Although there have been many technical and scientific improvements
in the HD treatment, hemodialysis cannot perfectly replicate healthy kidney function.
Patients on HD are at increased risks for developing additional conditions, such as
electrolyte abnormalities, anemia, infection, and cardiovascular dysfunction, therefore the
risks of morbidity and mortality are significantly elevated for these individuals.17–19
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1.3

The Heart

This section provides an overview of the anatomy and physiology of the heart while
extending these concepts to states of disease.

1.3.1

Cardiac Anatomy

The human heart is a muscular organ about the size of a fist, and is located in the center
of the chest, slightly to the left. The heart is the central pump of the cardiovascular
system consisting of walls, chambers, valves, arteries, veins, and an electrical conduction
system. The anatomy of the heart can be visualized in Figure 1.4. The heart consists of
four chambers: the right atrium, left atrium, right ventricle, and left ventricle. The septum
is the portion of these chamber walls that divides the heart into its left and right sides.
There are 4 important valves that separate each of the chambers: the right atrioventricular
(AV) or tricuspid valve, the pulmonary semilunar valve, the left AV or bicuspid valve,
and the aortic valve. The major veins connecting to the heart include the superior and
inferior vena cava and the pulmonary veins, whereas the major arteries connecting to the
heart include the pulmonary arteries and the aorta. The heart also contains an electrical
conduction system with specialized nodal and conducting cells. These cells make up the
sinoatrial (SA) node, AV node, bundle of His, and Purkinje fibers.
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Figure 1.4: Labelled diagram of the heart, including its chambers, valves, arteries,
veins, and septum. Created with BioRender.com.

1.3.2

Cardiac Physiology

The main function of the heart is to pump blood throughout the body to deliver oxygen,
nutrients, and hormones to all tissues while regulating body temperature. The heart serves
these functions by pumping oxygen-poor blood into the pulmonary circulation to reach
the lungs and pumping oxygen-rich blood into the systemic circulation to reach the
remainder of the body. It is the atria that receive blood from major veins, and the
ventricles that pump blood throughout the circulation with the help of major arteries. The
left ventricle is the main pumping chamber of the heart, and the walls of this chamber are
very thick and muscular because they must contract with a great amount of force to pump
blood into the systemic circulation. This is one of the reasons why the left ventricular
wall, and specifically the septum, are of particular interest in this thesis.
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The blood flows through the heart in one direction. This begins with the right side of the
heart as oxygen-poor blood is received by the superior and inferior vena cava, flows
through the right atrium and ventricle, and is pumped to the lungs through the pulmonary
arteries. Once this blood is re-oxygenated, it returns to the left side of the heart through
the pulmonary veins, flows through the left atrium and ventricle, and is pumped to the
rest of the body through the aorta. It is each of the four valves that prevent the backflow
of blood throughout this process.
The electrical conduction system controls the heart’s rhythmic contractions. This system
is responsible for generating an electrical stimulus and allowing it to travel throughout
the heart. The electrical stimulus begins in the SA node, transfers to the atrioventricular
AV node, extends through the bundle of His, and finally travels through the Purkinje
fibers to contract both atria then both ventricles in synchrony. These cells are organized
in such a way that the atria contract from top down to push blood down into the
ventricles, and the ventricles contract from bottom up to push blood out into the
circulation.
At the cellular level, the heart is made up of muscle cells called cardiac myocytes. These
myocytes produce action potentials with the movement of ions through channels in the
cell membrane to change the membrane electrical potential and allow muscle contraction.
The ions involved in this process include Na+, calcium (Ca2+), and potassium (K+).20
Figure 1.5 shows a representation of the cardiac action potential. The cardiac muscle cells
are tightly bound to one another to allow this electrical impulse to travel quickly
throughout the heart.
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Figure 1.5: Visual representation of the change in myocyte membrane potential due
to movement of ions through channels in the cell membrane over the duration of a
cardiac action potential. Created with BioRender.com.
The electrical conductance of the heart can be measured by an ECG, which is recorded by
placing leads on the patient’s chest to detect the electrical potential of the heart
throughout the cardiac cycle. The ECG is a graph of voltage versus time of the heart’s
electrical activity which can be broken down into the P wave, QRS complex, and T wave
(Figure 1.6). The P wave represents the depolarization of atrial muscle, and QRS
complex is the depolarization of ventricular muscle, and the T wave is the repolarization
of ventricular muscle. The ECG trace of an individual can provide information on their
heart rate and can evaluate disturbances in rhythm or conduction.
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Figure 1.6: Placement location of ECG leads on patient's chest and resulting ECG
signal of voltage versus time. Representation of ECG signal includes labelled P
wave, T wave, and QRS complex. Created with BioRender.com.
Overall, the cardiac cycle is separated into two main phases: systole and diastole. Systole
occurs when the heart contracts to eject the blood, and diastole occurs when the heart
muscle relaxes to fill with blood. Figure 1.7 gives a representation of the pressure,
volume, and electrical conductance of the heart throughout the cardiac cycle.
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Figure 1.7: Visual representation of the LV pressure, LV volume, and electrical
conductance of the heart throughout one cardiac cycle, as well as systole and
diastole phases. EDV and ESV are labelled in green and red respectively. Created
with BioRender.com.
There are a few parameters that are important for assessing the mechanical performance
of the heart. These parameters include end diastolic volume (EDV), end systolic volume
(ESV), stroke volume (SV), cardiac output (CO), and left ventricular ejection fraction
(LVEF). EDV is the amount of blood in milliliters in the ventricles at the end of
ventricular diastole (just before contraction), and ESV is the amount of blood in the
ventricles at the end of systole (just after contraction). Using these parameters we can
calculate SV, the amount of blood pumped by the ventricles during one contraction.
𝑆𝑡𝑟𝑜𝑘𝑒 𝑉𝑜𝑙𝑢𝑚𝑒 (𝑆𝑉) = 𝐸𝐷𝑉 − 𝐸𝑆𝑉

[1.1]

CO explains the amount of blood that is pumped by the ventricles in one minute in units
of liters per minute. CO is calculated using the following equation:
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𝐶𝑎𝑟𝑑𝑖𝑎𝑐 𝑂𝑢𝑡𝑝𝑢𝑡 (𝐶𝑂) = 𝐻𝑒𝑎𝑟𝑡 𝑟𝑎𝑡𝑒 (𝐻𝑅) × 𝑆𝑡𝑟𝑜𝑘𝑒 𝑉𝑜𝑙𝑢𝑚𝑒 (𝑆𝑉)

[1.2]

LVEF is another important cardiac parameter that explains the amount of blood that’s
pumped out of the LV in one heartbeat, and it’s typically expressed as a percent of blood
that was in the ventricle prior to contraction. LVEF is calculated using the following
equation:
𝐿𝑒𝑓𝑡 𝑉𝑒𝑛𝑡𝑟𝑖𝑐𝑢𝑙𝑎𝑟 𝐸𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 (𝐿𝑉𝐸𝐹) =

1.3.3

𝑆𝑉
𝐸𝐷𝑉

× 100

[1.3]

Cardiovascular Disease (CVD) in CKD Patients

Cardiovascular disease (CVD) is a term used to address a group of disorders of the heart
and blood vessels. It has been determined that patients with CKD are at an elevated risk
for developing CVD from an early stage, but the exact mechanism interrelating these
diseases remains unclear. CVD is the leading cause of death worldwide and in the CKD
population.21 Patients with CKD are more likely to experience cardiovascular
complications or death than progression to end-stage renal disease.17 CVD in CKD
patients differs from CVD in the general population because the outcomes in CKD
patients are not fully accounted for by the traditional risk factors for these diseases, such
as age, family history, obesity, diabetes mellitus, and increased blood pressure and
volume. In CKD patients, cardiovascular complications include the traditional and nontraditional risk factors. The adverse cardiovascular complications associated with patients
with CKD are often collectively termed uremic cardiomyopathy, and include
complications such as coronary artery disease, arterial stiffness, calcification,
inflammation, and myocardial stunning that can lead to sudden cardiac death.22
In patients with CKD, the heart as well as its vascular system undergo structural and
functional remodeling. Coronary artery disease is extremely prevalent in CKD patients
and involves the build-up of plaque in the arteries that supply the heart with oxygen-rich
blood.23 These same arteries are also known to become stiff and develop calcifications,
specifically in patients with CKD stage 5 and are predictors of all-cause and
cardiovascular mortality.24 Vascular calcification and stiffness have been found to
correlate with one another, although the mechanisms by which these issues relate remains
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unknown.25 CKD is also known to cause a chronic inflammatory state in the body that is
the result of a multitude of factors such as acidosis, oxidative stress, increased proinflammatory cytokines, and increased numbers of infections. This inflammatory state
contributes to the cardiovascular complications these patients experience, and it is
especially prevalent in those on hemodialysis.26 The hemodialysis therapy itself can cause
myocardial stunning: reductions in LV wall motion due to repetitive interruptions in
blood flow.27 Continuous renal replacement therapy can lead to permanent LV
dysfunction as the damage from these ischemic events are cumulative and persist even
after reperfusion.28,29 Each of these factors come together to increase the risks of heart
failure, arrythmia, and sudden cardiac death in individuals with CKD.
Even with this knowledge, the manifestation of CVD in CKD remains unclear with many
different factors at play. Much additional research must be conducted to address this
comorbidity. In recent work, two cardiovascular complications that have been found to be
of specific interest in patients with CKD include diffuse myocardial interstitial fibrosis
and LVH.22,30

1.3.3.1

Myocardial Interstitial Fibrosis (MIF)

Fibrosis is a scarring event that can present itself in different manners depending on the
disease. It is common for patients that have experienced a myocardial infarction to have
fibrosis localized to the cardiac tissue affected,31 but patients with CKD most commonly
experience a diffuse pattern of fibrosis termed myocardial interstitial fibrosis (MIF).5
MIF is the diffuse excess deposition of fibrous tissue or collagen in the extracellular
matrix of the myocardium. Collagen is the main structural protein in the human body and
can contribute to stiffness and therefore LV dysfunction when it accumulates in the
myocardium.32,33 Biopsy and imaging studies have confirmed that patients with CKD
have high levels of MIF that correlate with stage of CKD and length of time on
dialysis.34,35 It has also been found that there is no progression in MIF biomarkers if
kidney function remains stable in patients with early-stage CKD.36 There is an unmet
medical need of connecting the incidence of MIF with CKD. It is predicted that the
progressive loss of kidney function initiates mechanisms that stimulate the production of
MIF in CKD patients. MIF itself leads to LV dysfunction , arrhythmias, disruptions in
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myocardial perfusion, and can therefore be used to help predict cardiovascular outcomes
in CKD patients.5

1.3.3.2

Left Ventricular Hypertrophy (LVH)

Left ventricular hypertrophy (LVH) is characterized by the enlargement of the heart’s left
ventricle caused by increased cardiomyocyte size. LVH is usually diagnosed based on the
calculated LV mass, but normal values will change based on the age, sex, and body
surface area of the individual.37,38 For this reason, values of LV mass are commonly
reported as LV mass index (LVMI) which is the mass of the LV indexed to the body
surface area in units of g/m2. In general, normal values of LVMI (mean  standard
deviation) for women are 49  10 g/m2 and 62  11 g/m2 for men.39 These values are
based on the inclusion of the papillary muscles in the LVMI measurement (Figure 1.8).
For the diagnosis of LVH, LVMI must be roughly  131 g/m2 for men and  100 g/m2 for
women.37

Figure 1.8: Short-axis image of healthy heart acquired with H+ MRI. Labelled: right
ventricle, left ventricle, papillary muscles, and left ventricular wall. Pink and purple
contours represent a step in LVMI measurement. Contours are drawn around the
LV wall and include papillary muscles. This image is from unpublished data in the
McIntyre lab.
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LVH is the first step of ventricular remodeling. In some cases, it occurs due to intense
athletic training, but it’s often the result of pathological conditions. One of the main
physiological mechanisms by which LVH occurs is pressure and volume overload in the
left ventricle. Cardiomyocytes counteract the increased stress to the walls of the heart by
expanding and the chamber thickens to result in LVH. Aside from this mechanism,
different diseases of the heart, genetics, or abnormal tissue growth in the heart muscle can
also cause LVH.38
It is common for patients with CKD to have LVH, with the prevalence of LVH being
inversely related to patient eGFR. Patients with CKD stage 1-3 are found to have a LVH
prevalence of 16-31%; 60-75% for stage 4-5; and over 90% once on dialysis. LVH in
CKD patients has been found to be associated with cardiovascular events and mortality
risk, however, the pathogenesis of LVH in CKD is poorly understood.2 One more recent
finding is that skin Na+ content has been found to correlate with LVH in patients with
CKD, suggesting that tissue Na+ levels may be a strong predictor of poor cardiovascular
outcomes.40

1.4

Biological Sodium (Na+)

The following sections provide a brief overview of Na+ in relation to the fluid
compartments of the body, the importance of Na+, and Na+ in disease.

1.4.1

Fluid Compartments

The majority of the Na+ in the human body is found in aqueous solution.41 This aqueous
solution is divided into intracellular and extracellular fluid, that contains about 2/3 and
1/3 of the total body water respectively. Na+ is the most prevalent cation in the
extracellular fluid. This compartment can be broken down further into the fluid found in
the blood (plasma) and the fluid outside of the blood (interstitial fluid). It is the Starling
equation that dictates the water flux between these two compartments:
𝑃𝑐 − 𝑃𝐼𝐹 = 𝜋𝑐 − 𝜋𝐼𝐹

[1.4]
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In this equation, 𝑃𝑐 is the capillary hydrostatic pressure of plasma, 𝑃𝐼𝐹 is the interstitial
fluid hydrostatic pressure, 𝜋𝑐 is the capillary plasma osmotic pressure, and 𝜋𝐼𝐹 is the
interstitial osmotic pressure. Hydrostatic pressure represents the pressure exerted by a
fluid, and osmotic pressure represents the pressure of fluid flowing inward caused by a
high concentration of solutes. The direction of the flow of fluid caused by these pressures
is shown in Figure 1.9 below.

Figure 1.9: Visual representation of hydrostatic (P) and osmotic () pressures
between the capillary and interstitial space, and the direction of fluid flow caused by
these pressures. Created with BioRender.com.

1.4.2

The Role of Sodium (Na+) in the Body

Na+ is an essential electrolyte involved in many cellular processes including the
transmission of nerve pulses, regulating the contraction and relaxation of muscles, and
maintaining fluid and pH balance. Na+ is found at a concentration of 140-150 mM in the
extracellular space, and 10-15 mM in the intracellular space.42,43 This concentration
gradient is maintained by the sodium-potassium adenosine triphosphatase (Na+/K+
ATPase) pump, which uses energy to pump Na+ out of and K+ into the cell (Figure 1.10).
There are also other mechanisms of Na+ transport through the cell membrane, such as the
sodium channels that allow sodium to flow into the cell and sodium proton (Na+/H+)
exchangers which exchange one proton for one sodium ion. Alterations in Na+
concentrations can indicate pathological conditions and have been investigated during the
study of myocardial infarction, osteoarthritis, diabetes, kidney disease, and more.44,45
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Figure 1.10: Visual representation of a human cell with the intracellular and
extracellular concentrations of essential ions, and a depiction of the Na+/K+ ATPase
pump. Created with BioRender.com.

1.4.3

Osmotically Inactive Sodium (Na+)

Na+ metabolism in the body has previously been considered steady state, where total
body water and Na+ remain constant as excess dietary Na+ is eliminated by the kidneys.
In this model, an increase in Na+ in any region of the body would be followed by an
increase in water volume to maintain the Na+ concentration in that area. Na+ that acts in
this manner is termed osmotically active Na+ (OA- Na+). Over the last 20 years, our
understanding of Na+ metabolism has changed. It was discovered that Na+ can
accumulate in tissue without being accompanied by excess water deposition.46 This Na+
is termed osmotically inactive Na+ (OI- Na+), and has been found in the skeleton, soft
tissues, and skin.47–49
Two mechanisms have been proposed for the accumulation of OI- Na+ in tissue. This first
mechanism suggests that in cellular dense tissues such as muscle, excess Na+ may be
stored intracellularly. The Na+ would be replacing intracellular potassium in order to
maintain cellular tonicity.41 The second mechanism can be attributable to OI- Na+
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accumulation in other tissues. In this mechanism, the positively charged Na+ is recruited
by negatively charged proteoglycans in the extracellular matrix removing its osmotic
abilities. This mechanism is supported by studies showing correlations between increased
proteoglycans and increased Na+ content in the skin.50
The accumulation of OI- Na+ has been studied in many disease conditions and has been
found to influence many biological processes and signal pathways, such as the immune
response, ischemia, and hypertension. Local OI- Na+ deposition has been linked to the
immune system as it has been found to influence immune cell function and
inflammation.9 A local increase of OI- Na+ has also been found in regions subject to
ischemia-reperfusion injury, specifically in the human myocardium.10,44 Additionally,
hypertension has been associated with the accumulation of OI- Na+ in the skin.51
Although these findings have shed light on some effects OI- Na+ has on its microenvironment, much remains unknown about its full implications and mechanisms. In
particular, the study of OI- Na+ storage in CKD and HD patients is currently a popular
research topic.

1.4.4

Sodium (Na+) in CKD

In the body, Na+ content is dictated by Na+ consumption and Na+ excretion, which are
assumed to be in equilibrium. Na+ excretion depends on losses through sweat, the
gastrointestinal tract, and mostly the kidneys. Since kidney function is compromised in
patients with CKD, they have difficulties maintaining Na+ balance in the body. This can
occur due to damage to the tubule that reduces its ability to reabsorb Na+, or damage to
the glomerulus that reduces Na+ filtration into Bowman’s capsule. The latter is most
common and results in increased Na+ retention. For this reason, patients with CKD are
prescribed low salt diets and diuretics to prohibit Na+ accumulation in the body.7
Diuretics work by decreasing the reabsorption of Na+ in the tubules of the nephrons
which increases the amount of Na+ removed by the kidneys.
Since the 1980s, dialysis units have been using higher dialysate Na+ concentrations to
limit the amount of Na+ removed in need of avoiding hypotensive conditions,
disequilibrium, and discomfort for hemodialysis patients.52 Unfortunately, these high
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concentrations of dialysate Na+ can lead to an influx of Na+ into the body instead of
removal.53 This increase in bodily Na+ increases fluid retention, which causes
hypertension, LVH, and heightened CVD risk.7 The accumulation of OI- Na+ in tissue
has also been found in HD patients, and is correlated with adverse outcomes.40,49,54

1.4.5

Sodium and Cardiac Injury

As sodium is an essential nutrient, its imbalance can be involved in mechanisms of
cardiac injury. The conventional understanding of Na+ and cardiac injury involves
increased volume and pressure. It has long been accepted that an increase in Na+
consumption will lead to an increase in blood pressure which is detrimental to cardiac
health. As OA- Na+ in the body increases, the body retains water causing extracellular
volume expansion to maintain Na+ concentration in the body. This extracellular volume
expansion increases the exerted pressure of the blood on the vessel walls, otherwise
known as blood pressure. An increase in pressure and volume overload is well known to
cause many cardiovascular complications such as LVH and increased risks of developing
CVD.7
The emerging relationship between Na+ and cardiac injury is much more complex and
involves factors far beyond pressure and volume overload. Firstly, Na+ has been found to
relate to cardiac injury in indirect ways such as through cardiac ischemia, inflammation,
sodium glucose co-transporter 2 (SGLT-2) inhibitors, the sodium-calcium (Na+/Ca2+)
exchanger, extracellular volume expansion, and Na+ deposition in distant tissues:
a) Cardiac Ischemic Reperfusion Injury
Patients on hemodialysis are prone to myocardial ischemia. Myocardial ischemia
involves the restricted or reduced blood flow and oxygen to the heart muscle.
Multiple dialysis treatments a week can exert stress on the cardiovascular system with
repeated ischemic events and may contribute to the incidence of heart failure in these
patients.55,56 It has been found that events of ischemia in the myocardium lead to
motion reduction in the LV wall that persists even after perfusion has been restored.27
This is called myocardial stunning. Repetitive episodes of ischemia-reperfusion injury
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can be cumulative and eventually lead to cardiac fibrosis.55 Modulating dialysate Na+
concentrations has shown promise for reducing intradialytic cardiac dysfunction for
patients undergoing hemodialysis treatment and potentially preventing
cardiomyopathy in these patients in the future.27 Beyond this, a substantial build-up of
intracellular Na+ was observed minutes after the onset of ischemia in preclinical
studies on the hearts of rats and ferrets.57–59 Similarly, OI- Na+ in the affected
myocardium has been found to correlate with ischemic conditions in the hearts of
humans.10,44
b) Inflammation
Inflammation is an immune reaction that occurs when the body senses an injury or
infection. There has been many research studies indicating that high consumption of
salt can induce immune responses in the body to promote inflammation and organ
damage.60–62 Inflammation is particularly common in patients on HD, which
contributes to their excess CVD risk.63 It has been found that increasing the amount
of Na+ removed during dialysis can reduce inflammation in HD patients and
subsequently reduce their chances of CVD events.64
c) Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors
The sodium glucose co-transporter 2 (SGLT-2) transports Na+ and glucose together
across the cell membrane and is important for glucose reabsorption in the nephron of
the kidney. SGLT-2 inhibitors prevent the action of this transporter and therefore
encourage the excretion of glucose and Na+ from the body. There has been much
research on the cardioprotective effects of these inhibitors.65,66 Not only have SGLT-2
inhibitors been found beneficial for heart failure patients, but they have also been
found to decrease adverse cardiovascular events, slow the progression of kidney
disease, and decrease overall mortality in CKD patients.66 Some of the possible
mechanisms of the SGLT-2 inhibitor positive effects include lowering blood pressure,
preventing inflammation, preventing ischemia, and inhibiting the Na+/H+ exchanger,
which would otherwise increase Na+ myocardial levels.67 With SGLT-2 inhibitors
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identified as beneficial for CKD and heart failure patients, it is possible that decreased
Na+ excretion and increased myocardial Na+ are involved in this comorbidity.68
d) Sodium-Calcium (Na+/Ca2+) Exchanger
The sodium-calcium (Na+/Ca2+) exchanger is an important membrane protein that
removes calcium from cells by exchanging them with Na+ but depending on the
electrochemical gradient, can also exchange in the opposite manner. It is known that
elevated intracellular Na+ is present in human failing myocardium.69 These increases
in intracellular Na+ can cause increased intracellular calcium through the work of the
Na+/Ca2+ exchanger. Remembering the importance of the calcium ion in myocyte
contractility, the increase of intracellular calcium can contribute to arrhythmia and
cardiac dysfunction.70
e) Extracellular Volume Expansion
During dialysis, much stress is placed on the cardiovascular system, which includes
intradialytic hypotension, ischemia, and the build-up of uremic toxins.30,71 These
stresses cause cumulative damage during dialysis which can result in the death of
cardiomyocytes and edema. What is left is a larger extracellular to intracellular
volume ratio in tissue. Since there is a higher concentration of Na+ in the extracellular
fluid, the Na+ content in this region may reflect this extracellular fluid volume
expansion. Studies by Rossitto et al. have predicted this phenomenon.72,73 In general,
HD patients are known for having extracellular fluid volume expansion.53,74 This
expansion of extracellular fluid is one of the factors that contributes to LVH which
we know is detrimental to heart health.30
f) Sodium Deposition in Distant Tissues
OI- Na+ deposition has been found to occur in many tissues in the body, such as skin,
bone, and muscle.49 An abundance of preclinical data suggest that OI- Na+ tissue
deposition may cause a chronic inflammatory state of the body and tissue remodeling.
In humans, the skin is known to be a major Na+ reservoir, creating an extracellular
volume expansion buffer as excess Na+ in the body is stored without water.50 A study
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by M. Schneider et al. discovered that skin Na+ concentration correlates with LVH in
patients with CKD.40 It has also been found that humans with severe heart failure
have very high levels of OI- Na+ storage in the skin.75 Studies such as these suggest
Na+ is linked with cardiac injury, especially in patients with CKD that have high
cardiovascular risk.49,76 Although, the mechanisms at play remain unclear.
Secondly, preclinical studies have shown a direct relationship between Na+ and
cardiac injury, suggesting Na+ may be deposited in the myocardium leading to tissue
remodeling.77 A study by Yu et al. examined the effects of increased dietary salt on
fibrosis in normotensive and hypertensive rats. It was found that myocardial Na+
deposition induces myocardial fibrosis in rats independent of hypertension.11 One of
the main aims of our future work is to determine whether this relationship between
myocardial Na+ deposition and cardiac fibrosis may be occurring in humans as well.

1.5

Magnetic Resonance Imaging (MRI)

MRI is a non-invasive diagnostic imaging tool that uses strong magnetic fields to produce
detailed anatomical images of the human body. To produce the images, it takes advantage
of the magnetic properties of nuclei in the human body. These 3-dimensional images can
then be analyzed for tissue pathologies and therefore help diagnose and treat various
medical conditions.
There are three main components in an MR scanner that work together to produce the
images: the main magnet, the radiofrequency (RF) coils, and the gradient coils. During an
MRI scan, the patient is placed inside the bore of the MRI machine (Figure 1.11), where
there is a strong and uniform magnetic field of strength 1.5-3 T for clinical scanners or 711.7 T for pre-clinical scanners. Many nuclei (including H+ and Na+) possess a magnetic
dipole moment. When a patient is placed in the MR scanner, these nuclear dipole
moments in the tissue precess around the direction of the main magnetic field (B0). The
distribution of precessing moment is slightly skewed in the direction of B0, giving rise to
a net magnetization (M) of the tissue in this direction (Figure 1.12a). An RF pulse is then
given to the body in the form of a radio wave, which tips the magnetization M away from
the direction of the B0 (Figure 1.12b). This causes the bulk magnetization to precess
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around B0. As the magnetization precesses it quickly returns to its equilibrium direction,
simultaneously inducing a small voltage in a receiver coil which is the detectable signal
for MRI. (Figure 1.12c).

Figure 1.11: Labelled diagram of an MRI machine, including the bore, main magnet
and coils, and patient table. Created in BioRender.com.

Figure 1.12: Magnetization of nuclei a) while aligned with main magnetic field, b)
immediately after an RF pulse, and c) after relaxation back to direction of main
magnetic field. Direction of net magnetization (M) and main magnetic field (B0)
indicated at each step. Created with BioRender.com.

27

There are two directions in which the relaxation of the magnetization is measured:
longitudinal and transverse. The longitudinal relaxation, also known as the spin-lattice
relaxation, quantifies the recovery of the longitudinal component of the magnetization
along B0. The time it takes to recover 63% of the equilibrium magnetization is referred to
as the T1 (spin-lattice relaxation) time (Figure 1.13a). The transverse relaxation, also
known as the spin-spin relaxation, explains the dephasing of spins by the transfer of
energy between neighboring nuclei. This transverse or spin-spin relaxation is
characterized by a time constant, T2, which represents the time it takes until only 37% of
nuclei spins are still in phase (Figure 1.13b). These T1 and T2 times vary between tissue
types.

Figure 1.13: Graphical representation of the a) longitudinal relaxation and b)
transverse relaxation of nuclei after an RF pulse. T1 and T2 times indicated on
graph. Created with BioRender.com.
To attribute the detection of signal to a certain location in the body and produce sets of 2dimensional images, the gradient coils are used. There are gradient coils for the x, y, and
z directions. These gradient coils produce a secondary magnetic field that alters the main
magnetic field as a function of position along each gradient direction. This allows for
spatial encoding of the MR signal.78

1.5.1

Pulse Sequences

To acquire images using MRI, the RF pulses and the gradients must be applied to the
tissue in a specific sequence. This sequence must allow for the change in nuclei

28

magnetization, slice selection, and spatial localization, and this must be repeated many
times to obtain multiple images. The order, strength, and duration of these gradients as
well as the type of RF pulse can be specified depending on the image information and
signal-to-noise ratio (SNR) desired. These unique sequences of applications of gradients
and RF pulses are referred to as pulse sequences. These pulse sequences have specific
parameters by which they are defined. A few of these parameters are:
1) Echo time (TE): the time it takes to receive a signal after the administration of the
RF pulse.
2) Repetition time (TR): the time between the start of the pulse sequence and when it
is repeated.
3) Flip angle (): the angle of which the longitudinal magnetization is tipped into the
transverse (xy) plane.
Pulse sequences are also instructions on how to record the signal produced from tissue in
the 2-dimensional spatial frequency domain called k-space. K-space contains low spatial
frequencies in the center of the domain and high spatial frequencies in the periphery. It is
then this frequency domain that gets converted to the spatial domain (the anatomical
image) through a mathematical operation called the Fourier transform.
The main pulse sequences used in this thesis produce images that are nuclear density
weighted. Nuclear density weighted images have signal intensity values that relate to the
number of nuclei in the area being imaged, therefore T1 and T2 weighting are both
minimized. These types of imaging sequences use long TRs and shorts TEs to achieve
this effect. Applications of these sequences include quantification or comparing relative
amounts of nuclei in specific anatomical regions between individuals.

1.5.2

Proton (H+) MRI

In theory, nuclei with an odd number of protons or neutrons can be imaged with MRI
because they have net nuclear spin and dipole moment. This includes nuclei such as H+,
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Na+, 19F, and 13C. Nuclei with an even number of protons and neutrons cannot be imaged
with MRI.
H+ nuclei have a net nuclear spin of ½. H+ nuclei are the most common nuclei used for
MRI because of their high abundance in tissue and their magnetic properties. H+ has the
largest gyromagnetic ratio of all nuclei, with a value of 42.58 MHz/T. The gyromagnetic
ratio is the ratio of a nuclei’s magnetic moment to its angular momentum. The larger the
nuclei’s gyromagnetic ratio, the higher its MR sensitivity.
For the MR scanner to specifically image the H+ nuclei, it needs to be tuned to excite
only the H+ nuclei. This is done by using an RF coil that is tuned for the specific Larmor
frequency (𝜔0 ) of the nuclei of interest, in units of megahertz. The Larmor frequency
depends on the magnetic field strength (𝐵0) in units of tesla and the nuclei’s intrinsic
gyromagnetic ratio (𝛾) in units of megahertz per tesla, and is calculated using the
following equation:
𝜔0 = 𝛾𝐵0

1.5.2.1

[1.5]

Cardiovascular Magnetic Resonance (CMR)

Cardiovascular magnetic resonance (CMR) is a medical imaging technique that can noninvasively assess the structure and function of the heart by imaging the organ with MRI.
For this reason, CMR is a diagnostic tool that can distinguish cardiac health from
disease.39 Cardiac structure and function are assessed using CMR by measuring specific
cardiac parameters from the images. These parameters include LVM, LV ejection
fraction (LVEF), EDV, ESV, and SV. Table 1.2 provides definitions and units for these
parameters, and the research paper by J. Schulz-Menger et al. provides more information
on measuring them.79
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Table 1.2: Parameters for Assessing Cardiac Function
Units
Left Ventricular

Grams (g)

Definition
Weight of the left ventricle.

Mass (LVM)
Left Ventricular

Percent (%)

Ejection Fraction

end of diastole that gets pumped out of the left

(LVEF)
End Diastolic

ventricle during one systolic contraction.
Milliliters (mL)

Volume (EDV)
End Systolic

Volume of blood in the left ventricle at the end
of diastole/ventricular filling.

Milliliters (mL)

Volume (ESV)
Stroke Volume

Percentage of blood in the left ventricle at the

Volume of blood in the left ventricle at the end
of systole/ventricular contraction.

Milliliters (mL)

(SV)

Volume of blood pumped out of the left
ventricle during one systolic contraction.

For CMR imaging, the conventional MRI sequences must be adjusted. This includes
ECG gating to account for the movement of the heart during image acquisition and
breath-holds to minimize motion from breathing. The typical technique used to acquire
CMR images is cine imaging. Cine imaging is used to capture cardiac motion by
synchronizing the signal acquisition to the cardiac cycle using an ECG. Cine images are
collected at different slices of the heart. For each slice, data is acquired continuously and
then separated into very short windows of time along the entire cardiac cycle. The data in
each of the sections is reconstructed into separate images which is referred to as
retrospective gating. Afterwards, the images along the cardiac cycle can be combined to
produce cardiac cine MRI.78

31

1.5.3

Sodium (Na+) MRI

MRI can also be adapted to detect Na+ nuclei. This can be done by using a custom RF
coil tuned for the specific Na+ Larmor frequency. Na+ is the second-most MR visible
nucleus present in the human body due to its concentration in tissue and its natural stable
isotopic abundance of 100%.45 Although, Na+ MRI is challenging because of its lower
sensitivity, which is about 1/11 the sensitivity of H+.8 This is mainly due to the
gyromagnetic ratio of Na+, which is 11.26 MHz/T. Additionally, Na+ has a net nuclear
spin of 3/2, giving Na+ a quadrupolar moment. Compared with H+, this causes faster spinlattice and spin-spin relaxation. The latter having a biexponential signal decay with a fast
and short component in human tissue.45 As a result, faster imaging must occur during Na+
MRI due to this rapid decay of signal. Na+ MRI is also known for having a very low
SNR, therefore imaging parameters must be adjusted to optimally image the Na+ nuclei.

1.5.3.1

Density Adapted 2D Projection Reconstruction (DA2DPR)
Pulse Sequence

A pulse sequence that has been successfully demonstrated for Na+ MRI and the pulse
sequence used in this thesis is the density adapted 2D projection reconstruction
(DA2DPR) pulse sequence.80,81 This sequence was optimized for implementation on a 3T MR scanner, producing an ultrashort TE of 1.2ms, a TR of 100ms, and a flip angle of
90. The values of these parameters produce an imaging contrast that is proportional to
tissue sodium concentration. Since transverse relaxation is very fast for Na+, the TE must
be ultra-short to measure signal from the tissue before it decays after excitation. The TR
is chosen to be long enough to allow the longitudinal magnetization to recover before
repeating the pulse sequence, this allows for a strong signal from all Na+ nuclei. Lastly,
the flip angle is 90 to tip the entire longitudinal magnetization into the transverse (xy)
plane to get the maximum signal per RF excitation pulse.
The DA2DPR pulse sequence is unique because it acquires k-space using radial
trajectories, starting from the center, and reaching out to the periphery of k-space. Along
each trajectory there is density adaption that ensures uniform k-space sampling to account
for the radial trajectories getting further apart from one another towards the periphery of
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k-space (Figure 1.14). This way, the higher and lower spatial frequencies are evenly
sampled which avoids blurring and SNR loss in the resulting images.

Figure 1.14: Graphical representation of k-space with radial trajectories for image
acquisition with DA2DPR pulse sequence. Spheres indicate k-space samples that are
closer together towards the end of trajectories to proportionately sample k-space.
Created with BioRender.com.

1.5.3.2

Sodium (Na+) MRI Applications

Some of the earliest research with Na+ MRI began in the early 1980’s.43,82 Since Na+
MRI images the Na+ nuclei, it can provide different information than conventional H+
MRI. Na+ MRI can detect local changes in Na+ concentration which are altered by
disease. For this reason, Na+ MRI has been used to non-invasively study the
manifestation of many diseases and evaluate therapies. Some of the diseases assessed by
Na+ MRI include diabetes, multiple sclerosis, osteoarthritis, kidney disease, and cancer in
response to chemotherapy.45,83
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Most relevant to this thesis, Na+ MRI of the human heart has been used to study
myocardial infarction, Conn’s syndrome, and Na+ content of the healthy myocardium. It
has been found that Na+ content of the human myocardium is elevated in myocardial
infarction which has been measured using signal intensities and absolute quantification of
sodium concentration.10,44 Myocardial Na+ content was also found to be elevated in
patients with Conn’s syndrome in comparison to controls using a ratio of tissue Na+
intensity to the intensity of a 100mM reference vial.84 This study by Christa et al.
suggests that the myocardium may be a novel site of Na+ storage. To mention for
reference, a few studies have found the myocardial Na+ content in the septum of healthy
individuals to be around 52 mM.85,86 This thesis will now attempt to prepare the imaging
protocol for future studies evaluating the myocardial Na+ content of the septum in CKD
patients and controls using cardiac Na+ MRI.

1.5.4

Radiofrequency (RF) Coils

As mentioned previously, RF coils are needed to transmit RF pulses at the Larmor
frequency to excite the nuclei and receive the resulting signal. These RF coils can be
specifically for transmitting, receiving, or both. There are many different types of RF
coils, and each of them can be tailored to the anatomical region being imaged. The most
common type of RF coil used for transmission is the built-in body coil surrounding the
entire patient which is used exclusively for proton imaging. As for receiver coils, there
are two types; volume coils and surface coils.78

1.5.4.1

Surface Coils

Surface coils are typically small receive-only RF coils that are placed on the surface of
the patient, over the anatomical area being imaged. Some of the advantages of surface
coils include that they are simple to manufacture in comparison to other coils and have a
high sensitivity near their surfaces. For this reason, they are often used for imaging
superficial structures. Surface coils are less desirable for imaging deeper anatomical
structures because their sensitivity decreases significantly with depth.78 Therefore, there
is a nonuniform signal intensity distribution in the resulting image.
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To overcome this disadvantage, the sensitivity must be corrected. Intensity correction
allows the proper display of intensity and the quantitative assessment of surface coil
images. Axel et al. describes methods to help obtain uniform image intensity over a
region of interest imaged using a surface coil.87 There are two methods in which the
intensity correction can be performed: using an additional image of a phantom or using
the blurred original image. To save time and to avoid image co-registration, the blurred
image method can be used, but using an image of a phantom allows for a more accurate
intensity correction. In general, the image of the desired object is acquired, and an image
of a uniform phantom. A uniform phantom refers to a reference object with uniform and
known imaging properties that is used to mimic tissue, and in this thesis, it is a container
filled with 150mM of sodium chloride dissolved in water. The phantom image is then
normalized (the image signal intensities are scaled to be between zero and one) and
divided into the image of the object. This proportionately increases the signal in the areas
of the image that are further away from the coil to compensate for the intensity drop-off.
These methods will be applied in this thesis to our surface coil Na+ MR images to allow
for relative assessment of the Na+ signal.

1.6

Objectives and Hypotheses

This thesis involves technical adaptations of Na+ MRI to image the cardiac tissue of
healthy participants. The objectives of this research are: 1) To determine the effect of
ECG gating on Na+ MR image quality, and 2) To develop a pipeline to correct cardiac
Na+ MR images for non-uniform surface coil spatial sensitivity. The hypotheses are: 1)
ECG gating will improve Na+ MR image quality, and 2) the signal intensity of Na+ MR
images acquired with a surface coil will be made uniform with the use of phantom
images for improved quantification of tissue sodium concentration. Chapter 2 examines
the effect of ECG gating on Na+ MR image quality.

35

Chapter 2

2

The Effects of ECG Gating on Na+ MR Image Quality

This chapter contains a technical analysis of the effects of ECG gating on Na+ MR image
quality with a condensed introduction (background, objectives, and hypotheses),
methodology, results, and discussion. This study was conducted preliminary to the main
study of this thesis presented in chapter 3 and was intended to be applied to future patient
studies.

2.1 Introduction
2.1.1

Sodium (Na+) in the Body

The sodium (Na+) ion is the most abundant cation in the human body. Its presence is vital
for inducing muscle contraction, transmitting nerve impulse, maintaining homeostasis,
and more. Separated by the cell’s semi-permeable membrane, the Na+ concentration
surrounding the cell is found to be 140-150mM in comparison to the intracellular
concentration of 10-15mM. This concentration difference is maintained by the sodiumpotassium pump, which consumes energy in the form of adenosine triphosphate to
transport these ions through the cell membrane. However, there are many mechanisms
that can affect this concentration difference. The proper balance of intra vs extracellular
Na+ is a measure of cell membrane integrity. Pathological changes such as the
impairment of the sodium-potassium pump, as well as edema, tissue injury, or necrosis
may lead to an increase in the Na+ concentration in tissue. Therefore, tissue Na+
concentrations can be indicative of disease.43,54

2.1.2

Sodium (Na+) MR Imaging & Applications

With Na+ as the second most visible nucleus with nuclear magnetic resonance, Na+
magnetic resonance imaging (MRI) can be used to non-invasively assess Na+
concentrations in the human body. As serum sodium measurements assess the electrolyte
balance of the entire blood pool, measurements of in vivo Na+ levels can provide
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specialized information of sodium content in specific regions. This becomes useful when
investigating diseases that result in a disruption of Na+ concentrations. These disease
conditions include kidney failure, osteoarthritis, diabetes, hypertension, myocardial
infarction, and more.45,83
A specific region of the body warranting further investigation of changes in tissue Na+
concentration is the myocardium. Increased Na+ levels in the human myocardium may
indicate ischemic disease, myocardial infarction, edema, loss of cell membrane integrity,
and more.8 Cardiac Na+ MRI can be used to assess myocardium Na+ levels, but this type
of imaging also brings forth unique challenges.

2.1.3

Challenges of Cardiac Sodium (Na+) MRI

Na+ may be the second-best nucleus to detect using MRI, but obtaining good quality
images remains challenging due to the lower tissue concentration, MR sensitivity, and
gyromagnetic ratio of Na+ in comparison to the conventional H+.8 This alone reduces the
SNR and resolution in the resulting images. With cardiac Na+ MRI, once you consider
the movement of the heart and lungs, obtaining quality images becomes more difficult.
Some of the most recent studies using cardiac Na+ MRI reported an SNR of 26  2 in the
myocardium and a resolution of (6 x 6 x 6) mm3.88 It is thought that using ECG gating
with cardiac Na+ MRI would result in a higher SNR.80 However, in a study by Lott et al.
the SNR of images that were sorted by cardiac motion were found to be lower than the
non-sorted images.86

2.1.4

Cardiac Sodium (Na+) MR ECG Gating

Retrospective gating is typically used for acquisition of cardiac Na+ MRI. This involves
continuous imaging with simultaneous acquisition of ECG data. Post imaging, only
image frames of the heart acquired during diastole are averaged and omits those acquired
during systole to create the final image. This reduces motion artefact in the final averaged
image. This strategy is considered to be the least SNR-costly method as it allows for
continuous data acquisition.8,80 Since cardiac Na+ MRI is a less common field of
research, ECG gating for sodium imaging hasn’t been widely investigated. Much of the
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research that has been undertaken on this topic is associated with 7-T scanners, which are
less clinically applicable; access to a 3-T scanner is far more typical.86,89,90 Regardless of
the field strength, the results from these studies demonstrated differences in measurement
of the myocardium Na+ signal of no more than 5% between ECG gated and non-gated
images.80,86

2.1.5

Objective and Hypothesis

The objective of this study is to determine whether cardiac gating of Na+ MR images
improves image quality by comparing retrospectively gated images to non-gated images.
This is important to determine for future studies that wish to quantify cardiac sodium
concentrations from Na+ MR images. Considering Na+ MRI has an intrinsically low
signal-to-noise ratio (SNR), we investigated changes to the point spread function (PSF),
SNR, and geometric distortion between the two image groups. Previous studies have also
been conducted to assess MR image quality with resolution, SNR, and geometric
distortion.91–93 The PSF is a measure of the spatial resolution of the imaging system using
the full width at half-maximum (FWHM) of its peak. Spatial resolution is an important
metric because it represents the smallest feature that can be resolved in the image. SNR is
another important imaging parameter that measures the amount of signal present in the
image in comparison to the amount of background noise or signal fluctuations. SNR is
therefore a measure of image quality. Lastly, geometric distortion can be a measure of
image artefact. This can be done in the cardiac Na+ MR images by measuring the septum
thickness to determine whether the ECG gated and non-gated images exhibit differences
in anatomical length measurements. Overall, it is hypothesized that cardiac Na+ ECG
gating will remove any geometrical distortion, maintain spatial resolution, but reduce
SNR. This is because cardiac motion will be removed from image acquisition, but this
omitted data will also reduce the amount of signal collected.
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2.2
2.2.1

Methodology
Study Design

This was a cross-sectional pilot study. During one study visit, each participant provided
demographic information before H+ and Na+ MRI scans of the heart were acquired.
This study was approved by the University of Western Ontario Health Sciences Research
Ethics Board before any study visits took place. The entirety of this study was conducted
in accordance with the approved protocol and Good Clinical Practice Guidelines.

2.2.2

Participants

The four study participants were recruited from London, Ontario, Canada. Participants
with a previous history of cardiovascular disease or those who did not pass the facility
screening form were excluded from this study prior to written informed consent. Age of
participants ranged from 35 to 48 years.

2.2.3

H+ and Na+ MR Acquisition

All H+ and Na+ MR image data were acquired using a 3.0-T MRI machine (Discovery
MR750, General Electric Healthcare, Milwaukee, WI, USA). Participants were
positioned supine and feet-first within the magnet bore.
Cardiac Na+ MR images were acquired using a custom-built two-loop (18cm diameter)
butterfly radiofrequency surface coil tuned for Na+ frequency (33.786 MHz). The coil
was placed around the chest and centred over the heart, with one loop on the anterior and
one loop on the posterior side of the body. The coil location was adjusted to ensure the
heart was placed in the centre of the two loops using proton anatomical images obtained
by the MRI built-in body coil which include fiducial markers incorporated into the RF
coil. A density-adapted 2-dimensional projection reconstruction pulse sequence for Na+
MRI was implemented with the following parameters: FOV = 36 x 36cm2, in-plane
resolution = 0.3 x 0.3cm2, slice thickness = 3cm, TR = 100ms, TE = 1.2ms, flip angle =
90 degrees, signal averages = 50, radial projections = 378, acquisition time = 31.5
minutes. The slice prescribed was a mid-short-axis slice of each participant’s heart.
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Simultaneous ECG data were also acquired during each scan using electrodes placed on
the chest, and the images were acquired while the participant was free breathing.
Cardiac H+ MR images were obtained using the built-in RF body coil. Short-axis images
covering the entire left ventricle were acquired using a 2D CINE fast imaging employing
steady state acquisition (FIESTA) pulse sequence with an 8-mm slice thickness, 2-mm
slice gap, 36 x 36-cm2 field of view, 224 x 224 matrix, 3.5-ms repetition time, 1.5-ms
echo time, 45-degree flip angle, 69-ms temporal resolution, 1.6 x 1.6 mm2 in-plane image
resolution, and 125kHz bandwidth. Breath holds and prospective ECG triggering were
used during the scan to gate the images. Sets of 25 images were collected across the
cardiac cycle for each slice. Number of slices and acquisition times varied between
participants as they depended on heart length and heart rate.

2.2.4

Data Analysis

The Na+ MR raw k-space data was reconstructed into four mid-short axis Na+ MR images
for each participant with a 2048x2048 matrix in MATLAB (Mathworks, R2020a, Natick,
MA) using a non-uniform fast Fourier transform. The four Na+ MR images were
retrospectively gated to contain data from 25%, 50% 75% and 100% of the cardiac cycle
as shown in figure 2.1.

Figure 2.1: Visual representation of the regions of the cardiac cycle during which
data was collected for the images containing a) 25%, b) 50%, c) 75%, and d) 100%
of data from the cardiac cycle. The R-R interval here represents one full cardiac
cycle.
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In MATLAB, the mid-short axis H+ MR images were used to create two H+ MR images
for each participant with a 2048x2048 matrix. The first was an average of all 25 images
(100% of the cardiac cycle), and the second was an average of the 14 images where the
ventricles were found to be in resting position (56% of cardiac cycle).

For the point spread function analysis, a simulation was used to represent the signal of a
3mm ideal object based on participant k-space image data. The object’s k-space data was
modified depending on the amount of data that was used to reconstruct each participant’s
gated and non-gated images (using 25%, 50% and 100% of their cardiac cycles). This
was performed in MATLAB using an inverse Fourier transform and a Fourier transform.
The resulting point spread functions were overlayed on one graph for comparison.

For the signal-to-noise ratio (SNR) measurements, regions of interest (ROIs) were drawn
around the right ventricle, left ventricle, septum, skin, and a small region of background
in each of the four Na+ MR images for each participant. The H+ MR images were used to
guide the drawing of the ROIs on the Na+ MR images. The mean signals and standard
deviations were extracted from each of the ROIs and used to calculate the SNR with the
following equation:
𝑆𝑁𝑅 =

𝑚𝑒𝑎𝑛 𝑠𝑖𝑔𝑛𝑎𝑙
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝑠𝑖𝑔𝑛𝑎𝑙

[2.1]

In MATLAB, the SNR measurements were plotted on the same graph for each
participant. The SNR measurements for the right ventricle, left ventricle, septum, and
skin were separately fit to a square root curve to represent the following association:
𝑆𝑁𝑅 ∝ √# 𝑠𝑎𝑚𝑝𝑙𝑒𝑠

[2.2]

The geometrical distortion of the images was assessed by measuring the septum thickness
in each of the H+ and Na+ MR images. In MATLAB, 18 line profiles were drawn
perpendicularly across the septum in order to cover a 3mm width, which was the original
resolution of the Na+ MR images (Figure 2.2a and 2.3a). The signal intensity was
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extracted at each point across each of the line profiles, and they were averaged to create
one line profile for each image that was plotted on a graph of signal intensity versus pixel
number (Figure 2.4 and 2.5). The same method was repeated to create a second line
profile perpendicularly across a separate region of the septum that was oriented at a 45degree angle with respect to the image orientation (Figure 2.2b and 2.3b). Using the line
profiles, the pixel width was calculated at the full width at half minimum with respect to
the closest local maximum in the H+ and Na+ images (Figure 2.4b and 2.5b) The septum
thickness at both regions in each image were then calculated according to the following
equation:
𝑆𝑒𝑝𝑡𝑢𝑚 𝑇ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠 = # 𝑝𝑖𝑥𝑒𝑙𝑠 𝑤𝑖𝑑𝑒 × 𝑑𝑖𝑚𝑒𝑛𝑠𝑖𝑜𝑛 𝑜𝑓 𝑒𝑎𝑐ℎ 𝑝𝑖𝑥𝑒𝑙

[2.3]

Figure 2.2: Short-axis H+ MR images of one participant’s heart depicting the line
profile location oriented a) horizontally and b) at a 45-degree angle.
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Figure 2.3: Short-axis Na+ MR images of one participant’s heart depicting the line
profile location oriented a) horizontally and b) at a 45-degree angle.

Figure 2.4: Plot showing the a) 18 line profiles and b) one average line profile across
the septum in a horizontal direction for one participant’s H+ MR image before
gating. The measured septum width is shown at full width half minimum with
respect to the closest local maximum.
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Figure 2.5: Plot showing the a) 18 line profiles and b) one average line profile across
the septum in a horizontal direction for one participant’s Na+ MR image before
gating. The measured septum width is shown at full width half minimum with
respect to the closest local maximum.

2.3

Results

The following sections describe the results of the PSF, SNR, and geometrical distortion
analysis of the reconstructed images. Figure 2.6 shows the visual differences between
sodium images of a participant reconstructed using different amounts of cardiac data.

Figure 2.6: Sodium images from one participant reconstructed using a) 25%, b) 50%, c) 75%, and
d) 100% of data from the cardiac cycle.
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2.3.1

Measuring the Point Spread Function (PSF)

Figure 2.7 shows PSFs of an ideal object that were reconstructed using different amounts
of k-space data. The amount of k-space data used for the reconstruction was based on
each participant’s gated and non-gated images (using 25%, 50% and 100% of their
cardiac cycles). Figure 2.8 shows each of these PSFs superimposed on one another. For
each participant, there was an increase in signal fluctuations surrounding the PSF the
further the images were gated and for the less data they contained from the cardiac cycle.
Although, when PSFs of the same participant were plotted on the same graph (figure 2.8),
the FWHMs of each PSF were identical.

Figure 2.7: Visual representation of an isolated pixel with its corresponding point
spread function (PSF) for an ideal image and images containing 25%, 50%, and
100% of data from the cardiac cycle for one participant. The PSF represents signal
intensity vs distance from the center of the pixel. One pixel is 3mm wide.
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Figure 2.8: Point spread functions (PSFs) of pixels from images containing 25%
(blue), 50% (red), and 100% (yellow) of the cardiac cycle of one participant plotted
on the same graph. The PSFs represent signal intensity vs distance from the center
of the pixel. The full-width-at-half-max (FWHM) for all PSFs is positioned on the
graph. One pixel is 3mm wide.

2.3.2

Measuring the Signal-to-Noise Ratio (SNR)

The average SNR measurements of the left ventricle, right ventricle, septum, and skin
were plotted against the percent of the cardiac cycle sampled for all participants (figure
2.9). Each tissue type was separately fit to a square root curve, resulting in an R2 of
0.9866 and above. For each individual participant, the images that were gated further
were found to have decreased SNR. This finding was consistent across all participants
and is displayed in figure 2.9.
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𝑆𝑁𝑅  √# 𝑆𝑎𝑚𝑝𝑙𝑒𝑠

Figure 2.9: Participant mean SNR for each tissue type separated by the percent of
the cardiac cycle data sampled in the image. A square root function was fit to the
data for the RV (R2=0.9990), LV (R2=0.9995), septum (R2=0.9998), and skin
(R2=0.9995).

2.3.3

Measuring the Geometrical Distortion

Geometrical distortion assessed by septum thickness measurements from each
participant’s Na+ images are displayed in Table 2.1. Septum thickness measurements
from each participant’s H+ measurements are displayed in Table 2.2. The septum
thickness measured in a horizontal direction across each of the Na+ and H+ gated and
non-gated images did not differ by more than 3mm for each participant. The same was
found when measuring the septum thickness with line profiles oriented at a 45-degree
angle with respect to the image orientation. Figure 2.10 shows how the line profiles and
septum widths changed as more cardiac data was included in the reconstruction of each
image.
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Table 2.1: Septum thickness means and ranges measured from each participant’s
Na+ MR images in two separate septum locations. Means include measurements
from all gated and non-gated images. Max-min represents the largest difference in
any two measured septum thicknesses.
Horizontal

45-Degrees

Mean  Std

Max - Min

Mean  Std

Max - Min

(mm)

(mm)

(mm)

(mm)

Participant 1

7.9  0.4

1.1

9.3  0.6

1.5

Participant 2

7.9  0.1

0.4

8.3  0.1

0.2

Participant 3

7.8  1.1

2.6

5.1  0.6

1.5

Participant 4

9.6  0.5

1.4

10.4  0.3

0.7

Table 2.2: Septum thickness means and ranges measured from each participant’s
H+ MR images in two separate septum locations. Means include measurements from
all gated and non-gated images. Max-min represents the largest difference in
measured septum thicknesses.
Horizontal

45-Degrees

Mean  Std

Max - Min

Mean  Std

Max - Min

(mm)

(mm)

(mm)

(mm)

Participant 1

9.5  0.0

0.0

9.5  0.3

0.5

Participant 2

10.0  0.2

0.4

8.2  0.5

1.0

Participant 3

6.5  0.4

0.7

6.1  0.1

0.2

Participant 4

8.5  0.3

0.5

9.8  0.1

0.2
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Figure 2.10: Line profiles and septum width measurements from sodium images of one
participant containing data from a) 25%, b) 50%, c) 75%, and d) 100% of the cardiac cycle.

2.4

Discussion

Retrospectively gated cardiac Na+ MR images acquired using a 3-T system do not exhibit
significantly improved image quality when compared with non-gated images as
determined by evaluation of PSFs, SNRs, and geometrical distortion.
For each participant, the FWHM of the PSFs of pixels from gated and non-gated Na+ MR
images were identical. Since the PSF is a measure of image resolution, it can be
confirmed that the spatial resolution is conserved when retrospectively gating cardiac Na+
MR images. However, the increase in signal fluctuations surrounding the peak of the PSF
indicate that there is greater image blurring in the images that are gated. The prescribed
in-plane resolution of our Na+ imaging system is also higher (3mm) than similar studies
investigating cardiac Na+ ECG gating (5-6mm), but our slice thickness was made larger
to maintain SNR.86,89,90
For images that are further gated, the SNR was found to be significantly lower.
Specifically, the SNR of all tissue types in the Na+ MR images increases according to the
square root of the percent of cardiac cycle data included in the image. This was observed
with R2 values of each data set being very close to one, representing an almost-perfect fit.
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This observation follows the expected relationship of SNR being proportional to the
square root of the number of samples in an image. The images that are retrospectively
gated have data omitted that were acquired when the heart was not at rest. These images
therefore contain less samples than the images that are not gated. This causes SNR to
decrease. Similar studies have also acknowledged that SNR decreases for cardiac sorted
data.86 To observe a similar SNR between gated and non-gated images, the number of
samples must be the same in both images, and therefore the data acquisition must be at
least 2-4 times longer. This is unrealistic in clinical settings, because the scan time for our
Na+ imaging session is around 30 minutes and patients usually struggle to remain inside
an MR scanner for any longer amount of time.
Regarding geometrical distortion, the maximum differences of cardiac septum
measurements between gated and non-gated Na+ images did not exceed 3mm. This is the
nominal resolution prescribed for this imaging experiment. A study investigating
different correction methods for cardiac Na+ MRI acknowledges that the effects of
cardiac motion on the resulting images are quite low compared to the spatial resolution of
the imaging system.86 The maximum differences of cardiac septum measurements
between gated and non-gated H+ measurements also did not exceed their resolution
(1.6mm). Therefore, there was no geometrical distortion detected in any of the images.
This identifies that retrospectively gating Na+ as well as H+ MR images does not increase
or decrease the apparent measurements of anatomical structures, specifically the septum.
Some limitations of this research study must be acknowledged. Na+ MRI is an imaging
technique with low resolution (3 x 3 x 30 mm). These large image voxels can lead to
partial volume errors in measurements, where voxels near the septum-ventricle barrier
may contain sodium signal from both blood and cardiac muscle. The cardiac septum also
changes in thickness throughout the cardiac cycle, although, the 3mm resolution is not
fine enough to detect any change. During the data analysis, ECG peak detection was done
manually since the magnet was not able to detect all heart beats. The Na+ images were
also only corrected for cardiac motion, and not respiratory. However, the H+ images were
acquired using breath-holds which lead to the same conclusions regarding geometrical
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distortion. Additionally, the subjects imaged in our study did not cover all the possible
cardiac differences, diseases, and rhythms that could potentially affect the results.
In conclusion, retrospectively gating cardiac Na+ MR does not improve image quality.
Specifically, when comparing retrospectively gated images to non-gated images the
spatial resolution and septum thickness measurements remained consistent, whereas the
SNR of the gated images decreased. These results can be applied to additional studies
using cardiac Na+ MRI, as extra scan time and technical adaptations can be avoided that
are involved in the retrospectively gating process. Although studies have mentioned that
cardiac gating must be used if quantifying the true myocardial Na+ signal from cardiac
Na+ MR images, tissue sodium concentrations between gated and non-gated images do
not differ by more than 5%.80,86 Another option may be to calculate ratios of cardiac Na+
signals from non-gated Na+ MR images, if comparing Na+ signals between participants
without gating is desired.
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Chapter 3

3

Intensity Correction for Cardiac Na+-MR Images
Acquired with a Surface Coil

This chapter contains an analysis of two different signal intensity correction methods for
Na+ MR images acquired with a surface coil with a condensed introduction (background,
objectives, and hypotheses), as well as the main methodology, results, and discussion of
this Master’s thesis.

3.1 Introduction
3.1.1

Sodium (Na+) in the Body

Sodium (Na+) is the most abundant cation in the human body. It has an extracellular
concentration that is 8-10 times higher than the intracellular, which is maintained by the
sodium-potassium pump. The Na+ ion is essential for many processes in the human body,
such as muscle contraction, nerve signal transmission, maintaining body water balance,
and more. For this reason, proper Na+ balance is needed to maintain regular cell
functioning, and disturbances in this balance can be indicative of disorders.43,54

3.1.2

Sodium (Na+) MRI

Among all biological nuclei, Na+ provides the second strongest nuclear magnetic
resonance signal in vivo, allowing it to be imaged with magnetic resonance imaging
(MRI). Na+ MRI is beneficial, as it allows the non-invasive and direct analysis of tissue
Na+ content, which is not possible by any other means. Therefore, imaging with Na+ MRI
can provide information on tissue viability and states of disease. Previously, this method
of imaging has been used to assess the tissue Na+ content of the brain in multiple
diseases, breast and prostate cancer, the heart after myocardial infarction, the kidneys in
patients with chronic kidney disease, and much more.45
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3.1.3

Sodium (Na+) in Kidney Disease

Na+ balance in patients with kidney disease is especially important because the kidneys
are responsible for the majority of Na+ excretion from the body. Na+ MRI has shown
promise for measuring dynamic sodium changes in healthy and diseased kidneys after
water consumption.94 Leg skin and muscle Na+ in hemodialysis, chronic kidney disease,
and heart failure patients has also been investigated to analyze trends in Na+ content.75,95
An important finding of recent studies using Na+ MRI, is that patients with kidney
disease have Na+ accumulation in their skin, bones, and muscle without excess water
deposition.47,48,96. Their skin Na+ content in particular has been found to be closely linked
with cardiac abnormalities such as increased left ventricular mass.40 Additionally,
preclinical studies have demonstrated salt to promote fibrosis in the left ventricle of the
heart.11 Combining this information with the known increased cardiovascular risk in
patients with kidney disease, it would be especially beneficial to analyze cardiac Na+
content in kidney disease patients using Na+ MRI.

3.1.4

Challenges of Sodium (Na+) MRI

Na+ MRI is difficult due to the inherent challenges presented by its nuclear properties and
the limited concentration of sodium in most tissues. The Na+ nucleus has a sensitivity for
magnetic resonance which is about 1/11th that of conventional proton MR imaging, and
the Na+ MR signal decays more quickly due to its quadrupolar moment.8,45 In addition to
its limited endogenous concentration, this causes Na+ MRI to have a very low signal-tonoise ratio (SNR). Furthermore, a radiofrequency (RF) coil tuned to specifically excite
and detect Na+ nuclei is required, which complicate the effort. These challenges
combined with cardiac and respiratory motion cause cardiac Na+ MR imaging to be
especially difficult. At clinical MR field strengths of 3T, surface coils are often used for
cardiac imaging.

3.1.5

Surface Coils

Surface coils are small (1-10cm diameter) RF coils that are used to image superficial
structures in the body. Since single-loop surface coils are the simplest type of coils, they
are commonly the first type of coil used for imaging nuclei other than protons.97 In Na+
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imaging, surface coils are often operated in transmit-receive mode; they are used to excite
the nuclei and detect the MR signal. Surface coils tend to have a higher signal-to-noise
ratio than other coils due to their limited size and ability to receive signal only from
nearby regions.98 This offers a benefit to be used for cardiac Na+ MR imaging, offering
high imaging sensitivity near their surfaces. However, sensitivity decreases rapidly with
increasing distance from the centre of the coil. This limitation creates a problem during
image analysis, as regions further away from the coil in the resulting image have a lower
signal intensity. In scenarios where images are to be quantified for sodium concentration
comparison between patients, this intensity drop-off must be corrected for.

3.1.6

Intensity Correction of Surface Coil Images

A paper by L. Axel et al describes two methods to correct for the intensity drop-off in
surface coil MR imaging.87 Using proton images of the wrist acquired with a 3cm wide
rectangular surface coil, this study corrected for the intensity inhomogeneity by acquiring
an additional image of a uniform phantom in the same position of the coil and divided the
wrist image by the normalized phantom image. In this study, this method will be referred
to as phantom correction. The second method they used involved dividing the original
wrist image by a blurred version of itself to give an approximate correction. We will call
this method self-correction. In our study, our objective was to analyze the accuracy these
two methods for correcting the intensity of Na+ MR images of calibration vials obtained
with an 18cm diameter surface coil, and then implement them in cardiac Na+ MR
imaging for future clinical applications. Our hypothesis was that the phantom intensity
correction method would be superior to the self-correction method, and that it would
adequately correct for the intensity inhomogeneity in Na+ MR surface coil images.
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3.2

Methodology

Figure 3.1: Flow chart displaying an overview of the project methods.

3.2.1

Study Design

This was a pilot cross-sectional cohort study where cardiac H+ and Na+ MRI scans of
participants were acquired during a single study visit. Before any study visits took place,
the study was approved by the University of Western Ontario Health Sciences Research
Ethics Board. This study in whole was conducted in accordance with the approved
protocol, Good Clinical Practice Guidelines, and all applicable regulatory requirements.
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3.2.2

Participants

The study participants were recruited from London, Ontario, Canada. Participants with a
previous history of cardiovascular disease or participants that did not pass the facility
screening form were excluded from this study prior to written informed consent. Age of
participants ranged from 23 to 37 years.

3.2.3

Sensitivity Correction Phantom MR Acquisition

All H+ and Na+ MR images in this study were acquired using a GE 3.0-T MRI system
(Discovery MR750, General Electric Healthcare, Milwaukee, WI, USA). The phantom
was a plastic container chosen to approximate the size of a human chest
containing150mM of NaCl dissolved in water.
All H+ MR images in this study were acquired using the built-in body coil in the MR
scanner. Axial images covering the entire length of the phantom in 61 slices were
acquired using a 2D fast imaging employing steady state acquisition (FIESTA) non-gated
pulse sequence with the following parameters: flip angle = 50, FOV = 36 x 36cm2, inplane resolution = 3 x 3 mm2, slice thickness = 3mm, repetition time = 3ms, and no
spacing.
All Na+ MR images in this study were acquired using a custom built single-loop (18cm
diameter) radiofrequency (RF) surface coil tuned for the Na+ nucleus (33.786 MHz). The
RF coil was placed on the top centre of the phantom, and a 100mM NaCl calibration vial
was positioned diagonally above the coil. There were also 6 vitamin pills placed within
the plane of the RF coil to act as fiducial markers during image processing, which were
visible in both H+ and Na+ images. The experimental setup is shown in Figure 3.2. The
pulse sequence used for Na+ imaging was a density adapted 3D projection reconstruction
(DA3DPR) pulse sequence with the following parameters: isotropic FOV = 36 x 36cm2,
resolution = 3 x 3 x 3 mm3, TR = 100ms, TE = 0.5ms, flip angle = 90, signal averages =
1, radial projections = 11310, acquisition time = 18.5 minutes. Axial Na+ MR images
were acquired in 61 slices with a slice thickness of 3mm, in-plane resolution of 3 x 3
mm2, and no spacing. The imaging sequence was repeated three times to increase SNR.
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Figure 3.2: Phantom experimental setup in the a) axial plane and in the b) coronal
plane showing the location of the vial and c) vitamin pills within the coil. The
phantom contained 150mM of NaCl and the external calibration vial contained
100mM of NaCl.

3.2.4

Calibration Vials MR Acquisition

H+ and Na+ MR images of a cluster of nine calibration vials were imaged, each with a
concentration of either 50mM, 100mM, or 150mM of NaCl. The arrangement of these
vials with respect to the RF coil is shown in Figure 3.3. The cluster of calibration vials
were submerged in a large plastic bin filled with 50mM of NaCl before scanning.

Figure 3.3: Visual representation of the arrangement of vials with respect to the RF
coil. Values represent the concentration of NaCl in each vial in millimoles per liter.
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For the H+ images, 61 axial images were acquired to cover the entire length of the
calibration vials with the same 2D FIESTA non-gated pulse sequence as the phantom H+
images (in-plane resolution 3 x 3mm2, slice thickness of 3mm, no spacing).
For the Na+ images, the RF coil was placed beneath the plastic bin, in the centre of the
cluster of calibration vials. The same external 100mM calibration vial was placed
diagonally beneath the RF coil, and the 6 vitamin pills remained inside the casing of the
RF coil to act as fiducial markers. A density adapted 2D projection reconstruction
(DA2DPR) pulse sequence was used to acquire one centre axial Na+ image slice of the
calibration vials with the following parameters: FOV = 36 x 36cm2, in-plane resolution =
3 x 3 mm2, TR = 100ms, TE = 1.2ms, flip angle = 90, signal averages = 50, radial
projections = 378, acquisition time = 31.5 minutes, and a slice thickness of 30mm.
These H+ and Na+ calibration scans were repeated three times on three separate days as a
measure of reproducibility.

3.2.5

Cardiac MR Acquisition

Cardiac H+ and Na+ MR images were acquired of each participant. Participants were
placed in the MR scanner in feet-first supine position with electrocardiogram leads placed
on their chest for cardiac gating purposes.
For the H+ images, 61 axial images were acquired to cover the entire length of the heart
with the same 2D FIESTA non-gated pulse sequence as mentioned previously (in-plane
resolution 3 x 3 mm2, slice thickness of 3mm, no spacing). One H+ mid-short-axis slice
was also acquired of each participant’s heart to guide the drawing of regions of interest
(ROIs) during image analysis. These images were mid-short-axis images prospectively
gated and acquired during repeated breath-holds with a 2D CINE FIESTA pulse sequence
with the following parameters: TR = 3.5ms, TE = 1.5ms, flip angle = 45, FOV = 36 x
36cm2, matrix = 512 x 512, slice thickness = 30mm, and 25 cardiac phases.
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For the Na+ images, the RF coil was placed on the participant’s chest above their heart
and the same 100mM calibration vial was positioned diagonally above the coil. The 6
vitamin pills remained in the casing of the RF coil to act as fiducial markers. The position
of the coil was adjusted, if needed, to have the centre of the coil directly above the centre
of the participant’s left ventricle. This was determined using H+ localizers obtained by the
built-in MR body coil. Before Na+ imaging, a shift reagent was used to ensure a 90 flip
angle. The same DA2DPR pulse sequence was used to acquire the cardiac Na+ MR
images. One cardiac Na+ mid-short-axis MR image slice was acquired of each
participant’s heart with an in-plane resolution of 3 x 3mm2 and a slice thickness of
30mm.

3.2.6

Image Processing

The Na+ MR raw k-space data was used to reconstruct the axial Na+ images for the
phantom and calibration vials with a 256x256 matrix in MATLAB (Mathworks, R2020a,
Natick, MA) using a non-uniform fast Fourier transform toolbox and re-gridding
algorithm.99
For each of the three calibration scans, the axial H+ phantom and axial H+ calibration
images were co-registered using 3D Slicer software (http://www.slicer.org).100 Images
were co-registered manually by applying a linear transformation to the axial H+
calibration images. This was done by aligning the fiducial markers in both images sets
that were visible within the imaging region of the RF coil. These same transformations
were then applied to the Na+ calibration image to ensure the Na+ calibration image was
co-registered with the Na+ phantom images. Using the linear interpolation resampling
module in 3D Slicer,100 one phantom Na+ slice was exported that contained all of the
phantom Na+ pixels that overlapped the Na+ calibration image slice. The intensity of each
pixel in the exported 3 x 3 x 30mm Na+ phantom slice was an average of the intensity of
all overlapping pixels in that region from the original Na+ phantom image set. This new
Na+ phantom image was a single slice that lay in the same region under the RF coil as the
Na+ calibration image that was needed for intensity correction.
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Before intensity correction, the mean signal offset that was created from noise was
subtracted from the Na+ calibration magnitude image. This was done in MATLAB
(Mathworks, R2020a, Natick, MA) by using the following equation that was described in
a paper by A. Miller and P. Joseph:101
𝑀𝑐 2 = 𝑀2 − 𝑀0 2

[3.1]

In this equation, 𝑀 is the raw image, 𝑀0 is the image background noise, and 𝑀𝑐 is the
image with the noise removed.

The intensity corrections were made using custom scripts written in MATLAB
(Mathworks, R2020a, Natick, MA) according to methods described by L. Axel et al.87
For the phantom correction, the Na+ phantom image extracted from 3D Slicer100 was first
normalized so all pixel intensity values were between 0-1. The Na+ calibration image
with noise removed was then divided by the normalized Na+ phantom image to produce
the phantom intensity corrected Na+ calibration image. For the self-correction, the Na+
calibration image was blurred and normalized, and the original image was divided by the
blurred version to produce the self-corrected Na+ calibration image. For images produced
by both methods, an ROI was drawn around the 100mM NaCl vial located above the RF
coil in the image, the mean was calculated, and the image was normalized using this
value. The image was then multiplied by 100 to scale the pixel intensity values to reflect
the actual Na+ concentration in the image.
Each of these steps (image reconstruction, co-registration, phantom Na+ image export,
noise removal, intensity correction, and image rescaling) were repeated for each
participant’s mid-short-axis cardiac Na+ image, just as they were for the calibration
images. The original calibration and cardiac Na+ images also underwent noise removal
and rescaling to serve as a comparison during image analysis. All final images were
exported to DICOM files.
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3.2.7

Image Analysis

The original and intensity corrected Na+ calibration images were analyzed using
MATLAB. The MATLAB code drew circular ROIs with identical diameters around each
vial and extracted mean Na+ signals and standard deviations.
All original and intensity corrected cardiac Na+ DICOM files were uploaded into the
medical image software viewer Horos (Version 3.3.6). In Horos, ROIs were drawn
around the external vial, left ventricle (LV), right ventricle (RV), and septum of the heart
in the original image using the mid-short-axis cardiac H+ images as a guide. These ROIs
were copy and pasted onto the phantom and self-corrected cardiac Na+ images of the
corresponding participants. Mean Na+ signal intensities were extracted from these ROIs
as well as their standard deviations.

3.2.8

Statistical Analysis

Interobserver variability was calculated between two independent readers (T.M and J.T).
The intraclass correlation coefficient was calculated for the signals of each vial (50mM,
100mM, and 150mM) between the three calibration scans and also between readers using
the two-way mixed model for average measures. The intraclass correlation coefficient
was calculated for the signals of each ROI (right ventricle, left ventricle, septum, and
external vial) in the cardiac Na+ images using the two-way mixed model for single
measures. Statistical analyses were performed with IBM SPSS software (IBM Corp.
Released 2021. IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY: IBM
Corp).

3.3
3.3.1

Results
Calibration Scans

The vials from the original, self-corrected, and phantom corrected calibration images of
one of the three calibration scans are shown in Figure 3.4. Visually, the vials that contain
the same concentrations of NaCl have a similar signal intensity after self-correction and
phantom correction.
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Figure 3.4: a) Arrangement of coil and vials with concentrations. b) The original, c)
self-corrected, and d) phantom corrected Na+ MR calibration images of one of the
three calibration scans.
Figure 3.5 displays a graph of mean signal intensities versus known Na+ concentration for
one of the three calibration scans. The values are separated by correction method, and
each data point is the mean of the three signal intensities of the vials of the same
concentration in the image. The slope of the line of best fit connecting these data points is
0.85 with 95% confidence interval [0.17, 1.5] for the phantom corrected and 0.26 with
95% confidence interval [-0.52, 1.0] for the self-corrected. The standard deviations of the
mean signal intensities were substantially lower in the phantom corrected and selfcorrected images compared to the original. The two remaining calibration scans provided
similar results, with their mean signal intensities shown in Table 3.1.
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Figure 3.5: Mean vial sodium signal intensities versus known sodium concentration.
Each data point represents the mean of three vial signal intensity measurements.
Error bars represent the standard deviation values for each data point.

Table 3.1: Mean Sodium Signal Intensities of Calibration Vials for Three Repeated
Scans

50mM
100mM
150mM

Original
(mean  std)
#1
#2
#3
56.9 
59.3 
57.1 
25.1
31.6
29.6

Self-Correction
(mean  std)
#1
#2
#3
128.8  129.0  129.6 
12.9
13.7
13.3

Phantom Correction
(mean  std)
#1
#2
#3
67.4 
77.9 
74.6 
7.2
20.5
17.9

97.6 
54.4
145.7 
88.1

148.3 
4.8
154.8 
6.2

122.1 
7.3
158.0 
15.5

102.9 
64.9
155.8 
100.0

100.5 
61.4
148.5 
84.4

148.7 
4.4
155.9 
7.2

147.7 
4.2
155.3 
6.9

123.1 
3.4
158.8 
7.8

121.7 
0.7
159.6 
13.2
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3.3.2

Cardiac Scans

Figure 3.6 shows a proton and uncorrected sodium mid-short-axis slice of one
participant’s heart that was used for analysis. Superimposing the images allows
visualization of the Na+ signal with respect to cardiac anatomy.

Figure 3.6: Mid-short-axis slice acquired by a) proton and b) sodium MRI. Proton
and sodium images are superimposed in image c). Increased intensity in the sodium
image represents higher sodium concentration in that region.
Original, self-corrected, and phantom corrected cardiac Na+ MR images of one
participant are shown in Figure 3.7. Visually, the region of the image that is more distant
from the coil (lower half) shows a boost in signal after correction by both methods.

Figure 3.7: The a) original cardiac Na+ MR image of one participant, and the image
after b) self-correction, and c) phantom correction with regions of interest (ROIs)
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displayed. The ROIs are labelled to show the right ventricle (RV), left ventricle
(LV), and septum (S). Coil location shown.
Figure 3.8 displays the mean Na+ signal ratios for the original cardiac Na+ images,
whereas figure 3.9 shows the ratios for the phantom corrected images. In comparison to
the original image values, the phantom corrected images provide much more consistent
ratios and lower uncertainties when using the signal in the ventricles as a reference. The
ratio of Na+ signal in the septum over the external vial did not give consistent results.
Table 3.2 shows groups averages of the sodium signal ratios measured from the phantom
corrected images.

Figure 3.8: Mean sodium signal ratios for the original cardiac sodium images.
Ratios are separated by participant number and ratio type. Ratios include the mean
signal in the septum over the mean signal in the right ventricle (RV), left ventricle
(LV), average signal in both ventricles (AVG), and external 100mM NaCl vial.
Error bars represent the uncertainty in each ratio, calculated from the standard
deviations of the signal intensities in each ROI.
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Figure 3.9: Mean sodium signal ratios for the phantom corrected cardiac sodium
images. Ratios are separated by participant number and ratio type. Ratios include
the mean signal in the septum over the mean signal in the right ventricle (RV), left
ventricle (LV), average signal in both ventricles (AVG), and external 100mM NaCl
vial. Error bars represent the uncertainty in each ratio, calculated from the
standard deviations of the signal intensities in each ROI.
Table 3.2: Group Averages of Sodium Signal Ratios for Phantom Corrected Images
Group Averages
(mean  std)

3.3.3

Septum/RV
0.71  0.05

Septum/LV
0.61  0.05

Septum/AVG
0.65  0.04

Septum/Vial
0.70  0.25

Interobserver and Interscan Variability

The intraclass correlation coefficient measures for interobserver variability were 0.97 for
the calibration vial scans and 0.99 for the cardiac ROIs. The intraclass correlation
coefficient for interscan variability between the three separate calibration vial scans was
0.99.
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3.4

Discussion

Cardiac Na+ MRI holds potential to measure and compare cardiac tissue Na+ signals
between healthy and diseased participants to provide clinical insight. Surface coils are
commonly used for this type of image acquisition at 3-T because of their simplicity,
increased local SNR, and ability to be positioned proximal to the anatomical region being
imaged. Their significant limitation is that signal intensity produced by these coils
decreases rapidly with depth into the participant, which often limits their application for
imaging deeper structures within the body. Correcting for this surface coil limitation has
been shown to increase successful diagnosis and decrease time of image interpretation as
mentioned in a study by Ren at al. studying spinal metastases with proton MRI.102 In this
work we set out to correct for the signal intensity drop-off in Na+ images acquired with a
surface coil using two separate methods, evaluate their reliability, and apply them to
human cardiac images. As the results of this study show, the phantom intensity correction
method is an accurate means of ameliorating the sensitivity profile of the Na+ surface coil
providing more image uniformity for sodium image analysis.

Although both the phantom correction and self-correction method appear to improve
signal intensity homogeneity, the self-correction method significantly decreases the
contrast in the resulting images. In the calibration scan analysis of the self-correction
method, all vials appear to contain similar signal intensities based on their brightness,
despite the change in vial NaCl concentration. The low slope of the self-corrected data
when measured Na+ signal is plotted against known Na+ concentration of the calibration
vials also displays this reduction in contrast. This is occurring because dividing an image
by its blurred version causes signal intensity values to converge, which also depends on
the degree to which blurring is performed. The blurring method used in this study was 2D
gaussian filtering, which was good for visualization but not quantification. The selfcorrection method therefore would not be an appropriate method to apply to images
before extracting and comparing image values between participants. This method would
not properly assess the underlying Na+ concentrations in tissue and would not be able to
characterise disease states.
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The phantom intensity correction method increases signal intensity homogeneity while
retaining image contrast. With this correction method, measured Na+ signal intensities
correlate with the known Na+ concentration in the calibration vials. This is shown by the
slope nearly equal to one in the mean vial Na+ signal intensity graph for this correction
method. The low standard deviations of this data set also show that vials of the same Na+
concentration consistently provide similar Na+ signal intensities. Although these two
observations are expected results of an ideal correction method, this method does not
have the ability to improve the SNR in areas distant from the surface coil. Other studies
using this correction method have also mentioned this limitation,87,103 which becomes
particularly applicable when using imaging modalities with low inherent SNR such as
Na+ MRI. This limitation impacts this study because measurements in regions more
distant from the coil will have higher noise, therefore measurements will have larger
standard deviation values and will be less precise.
When applied to human cardiac Na+ MR images, the phantom intensity correction
method once again visually improved signal intensity homogeneity. The ratio of mean
Na+ signal in the cardiac septum over the mean Na+ signal measured from the blood pools
in the ventricles provides a consistent value to represent the cardiac Na+ signal in a
participant. Our group average value of myocardial to blood Na+ signal after correction
(0.65) is very similar to the same ratios interpreted from the results of other research
papers (0.66-0.68) that investigated cardiac Na+ signals of healthy participants using
various acquisition methods with field strengths other than 3T.90,104,105 The blood in the
ventricles provides an internal standard to compare with the myocardial signal if the Na+
in the blood has low inter and intrasubject variability. However, controls and patients
with CKD are likely to have high variability of serum sodium levels. Internal standards
have been successfully used in Na+ imaging previously, with the Na+ signal of
cerebrospinal fluid used to estimate the Na+ concentration in the intervertebral disk.103
Ventricular blood as an internal standard could be used in future studies to compare
cardiac tissue Na+ signals between healthy and diseased participants if serum sodium was
collected. However, one limitation with using the signal of blood in the ventricles
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includes the blood signal varying depending on the direction and velocity of blood flow
during imaging.
The external Na+ calibration vial in the cardiac scans was not found to be a reliable
standard for measurement, as it led to inconsistent Na+ ratios. A study by Christa et al.
studying cardiac Na+ signals in patients with primary hyperaldosteronism and controls
found the Na+ signal ratio of interventricular septum to an external 100mM NaCl vial in
controls to be 0.21. Sensitivity correction was incorporated in this study, but their ratio
substantially differs from our observed results. It is not possible to determine the reason
for the differences without details on their intensity correction methods. Other studies
have reported explicit measurements of Na+ signal concentrations. Lott et al. reported a
myocardial tissue Na+ concentration of (54  5) mM before correction,104 and Ouwerkerk
et al. reported (53  12) in the septum.105 Based on these studies, a Na+ signal ratio of the
septum to an external 100mM NaCl should give a value closer to 0.54. During our image
analysis, it was noticed that our external vial was not producing a uniform signal intensity
to be used as a reference, as its measurement was giving a high standard deviation. This
could be attributed to the change in the orientation of the 30mm thick image slice
between participants, always perpendicular to the cardiac long axis, which was not
always perpendicular to the vial. To solve this problem, a uniform sheet phantom was
tested but was found to affect patient comfortability in the scanner. Since the external vial
was used to rescale the images, cardiac Na+ values are displayed as ratios and not true
concentrations. The Lott et al. group was able to report explicit cardiac concentrations
because they were using a 7T scanner with a birdcage coil.104 With 3T scanners such as
the scanner used in our study, a surface coil must be used to acquire optimal SNR in the
resulting images, and therefore requires intensity correction. The Ouwerkerk et al. group
quantified cardiac Na+ using adiabatic pulses and reference vials, but with axial images of
the heart.105 We acquired mid-short-axis images in our study to minimize partial volume
effects in the heart, which limited our ability to report absolute Na+ concentrations using
the reference vial.
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In conclusion, the phantom intensity correction method is adequate to correct for the
intensity drop-off in surface coil Na+ MR images and has been proven to be reproducible.
This method shows promise to be able to identify whether the cardiac septum is a novel
site of Na+ storage, and whether cardiac Na+ tissue content may be involved in negative
cardiovascular outcomes in kidney disease patients.
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Chapter 4

4

Conclusions and Future Work

This chapter contains a summary of the overall findings in this thesis, limitations of the
research, and expected future work.

4.1

Discussions and Conclusions

Chronic kidney disease (CKD) is known to be a major risk factor for cardiovascular
disease, however, the direct link between these conditions remains unclear. Patients with
CKD have damaged kidneys that can lead to inadequate removal and accumulation of
sodium. In CKD patients on hemodialysis therapy, this has been found to occur in the
skin, bones, and muscle.49 Specifically, in preclinical studies sodium accumulation in the
myocardial tissue has been found to induce fibrosis formation and other factors that
contribute to heart failure.11,77 This study was created with the intent of quantifying
myocardial tissue sodium in healthy and diseased kidney patients with cardiac Na+ MRI
to determine whether increased myocardial sodium correlates with myocardial fibrosis
and cardiac abnormalities. However, before myocardial tissue sodium could be properly
measured and compared between individuals, the imaging pipeline had to be optimized.
Therefore, this thesis focused on technical adaptations of cardiac Na+ MRI, including
cardiac electrocardiogram (ECG) gating and signal intensity correction. This study
investigated whether implementing ECG gating would increase image quality, and
whether the signal intensity inhomogeneity from surface coil imaging could be
adequately corrected.
In chapter 2 of this thesis, we investigated whether implementing ECG gating would
improve our cardiac Na+ MR image quality. Image quality was assessed using image
SNR, point spread functions for resolution, and geometrical distortion. Contrary to our
hypothesis, our images acquired with retrospective ECG gating did not have improved
image quality. Gated images had a decreased SNR, whereas spatial resolution and
geometrical distortion measured by point spread functions and septum thicknesses
remained unchanged. It was found that future studies using Na+ MRI at in-plane
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resolutions of 3 x 3 mm2 can avoid the extra havoc of implementing gating – if all
imaging parameters are kept equal, gating reduces SNR due to data omitted during
cardiac contraction.
In chapter 3 of this thesis, we determined an imaging pipeline to adequately correct the
signal intensity inhomogeneity in our Na+ MR images caused by surface coil imaging.
This pipeline included removing the noise from the raw images, imaging a phantom with
uniform saline concentration, and dividing the cardiac Na+ images by the phantom Na+
images. It was first assessed using a sodium calibration vial scan, where it was found to
increase signal intensity homogeneity, providing signal intensities that are proportional to
the known sodium concentrations in the vials. The pipeline was then used on cardiac
images to assess whether it could be used for future imaging studies that measure and
compare myocardial sodium signals. It was found that after intensity correction, the ratio
of mean Na+ signal in the cardiac septum over the mean Na+ signal of ventricular blood
provides a consistent value to represent myocardial sodium signal. In the future, studies
comparing myocardial sodium between individuals can use the blood in the ventricles as
an internal reference standard if serum sodium is collected.
This study contributes to existing literature as it provides additional information on
imaging techniques and post-processing needed for cardiac Na+ MR image analysis.
Similar studies have investigated the effects of ECG gating on cardiac Na+ MR imaging,
although, these studies were using scanners with higher field strengths and lower
resolution.86,89,90 Our study used an in-plane resolution of 3 x 3 mm2 and a 3-T scanner,
which are easier accessible and clinically applicable. Previous studies have also
implemented intensity correction techniques, using additional images of a uniform
phantom to correct signal non-uniformity created by surface coil imaging.87,103 Our study
is the first to successfully apply these methods to cardiac Na+ MR images. Na+ MRI is an
evolving field of research, specifically in terms of tissue sodium quantification in disease
states. In healthy controls, previous literature using various methods have mentioned
septum to ventricle blood sodium ratios that are highly comparable to our findings.85,86,90
The results of this study will therefore allow myocardial tissue sodium content to be
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assessed and compared between healthy individuals and those with cardiac complications
– such as patients with kidney disease.

4.2
4.2.1

Challenges and Limitations
COVID-19 Pandemic

The COVID-19 pandemic has substantially impacted graduate student research and
experience over the past two years. For my intended project, the pandemic delayed
research ethics board approval and affected the recruitment of participants. Participants
were more hesitant to volunteer for a scan due to the risks of spreading COVID-19. The
extra safety protocols in place also added extra barriers to participation. Access to the
scanner was denied during the lockdowns, and scan time was hard to come by when
research centers reopened. The majority of the work for my thesis was completed
remotely, with less access to mentorship and resources. Regardless, I was able to
complete a meaningful study with results that will influence future work in our
laboratory.

4.2.2

Limitations of Na+ MRI

Na+ MRI is a valuable imaging tool, however, it has many limitations when compared to
conventional H+ MRI. Sodium has a much lower concentration in the body, giving rise to
Na+ MRI’s lower sensitivity which is about 1/11th of H+ MRI. Its lower sensitivity is also
due to sodium’s lower gyromagnetic ratio (11.262 vs. 42.577 MHz/T). The sodium
nucleus also has a spin value of 3/2 creating a quadrupolar moment. The quadrupolar
moment causes the sodium MR signal to decay much faster than the proton with short T1
and rapid bi-exponential T2 relaxation. Each of these factors contribute to the lower SNR
in Na+ MR images. To overcome these challenges, imaging is done at lower resolutions
and image sequences are often much longer to collect more signal data. In our study, our
in-plane resolution was 3 x 3 mm2, our slice thickness was 30mm, and our acquisition
was 31.5 minutes to collect enough data to achieve an adequate SNR for analysis.
Additionally, the MR scanner must be equipped with transmit and receive RF coils that
are tuned to the specific resonant frequency of the sodium nucleus. This imaging
hardware for Na+ MRI is not widely available and can be costly to manufacture. For our
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study, our RF coils were custom-built for our needs, which took a lot of tuning and
modifications. Even with these adaptations, Na+ MRI has limited ability to recover
anatomical structures, provide detailed accurate information, and would have challenges
being applied in a clinical setting.

4.2.3

Sodium Quantification

One of the goals of our work was originally to quantify myocardial tissue sodium.
Quantification was eventually not found to be feasible with the imaging protocol and
pipeline used. Hence, sodium signal ratios were used in chapter 3. For quantification to
be possible, the signal intensity in Na+ MR images must be uniform, proportional to the
sodium concentration in vivo, and a reference of known sodium concentration in the
image is needed. In our cardiac Na+ MR images, our reference vial did not produce a
uniform signal intensity needed for quantification. Regardless, sodium signal ratios were
still able to provide us with a relative sodium signal in comparison to an internal standard
that can be compared between individuals or patient groups in future studies.
Alternatively, sodium could potentially be quantified from the images by using the blood
as an internal reference if a basic metabolic panel of the participant is done to determine
blood sodium concentration during the study visit. However, the sodium signal from
ventricular blood in the resulting MR image can vary depending on the velocity and
direction of blood flow.

4.2.4

Application to Future Work

Cardiac Na+ MRI is a field of study warranting further investigation, however, future
studies may have challenges applying our results to patient groups. Since MRI is a quite
expensive imaging modality, population sizes in this study were kept small. The goal was
to find preliminary results to apply to a larger patient study in the future. Considering the
small number of participants, we did not image all possible cardiac variations. We only
imaged healthy participants, so it’s likely other challenges will be encountered when
applying these imaging methods to diseased individuals. Specifically, those with cardiac
arrythmias, LVH, or other cardiac abnormalities. Our imaging protocol is also quite long,
with our acquisition time totaling to about 1.5 hours after Na+ and H+ MRI. This protocol
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also included additional sequences being investigated for application to the future patient
study. From experience, some patients have difficulties remaining inside the scanner for
longer than 30 minutes. This is another reason why it may be difficult to apply our
imaging protocol to future patient studies. Additionally, the results of this study are only
attributable to current sodium imaging systems using an in-plane resolution of 3 x 3 mm2
and a slice thickness of 30mm. If resolution were to increase, our results may no longer
be applicable. Due to all these limitations, the specialized equipment needed for sodium
imaging, and the post-processing required, Na+ MRI is far from being implemented in
clinical settings for diagnosis and treatment purposes.

4.3

Future Work

As mentioned, this study was conducted preliminary to an intended study that will
analyze myocardial sodium content of kidney disease patients and controls. The goal of
this future work is to determine whether sodium content in the septum correlates with
biomarkers for cardiac fibrosis and cardiac abnormalities in patients with compromised
kidneys. This study is currently underway as it’s using the results of the technical
adaptations tested in this thesis for sodium imaging. Specifically, this study is using the
phantom intensity correction method and sodium septum ratios presented in this thesis to
be able to compare septal sodium content between individuals.
This study will be imaging hemodialysis patients, patients with chronic kidney disease,
and healthy controls using Na+ and H+ MRI. Na+ MRI will be used to assess sodium
content in the septum, and H+ MRI will be used to assess cardiac function. Measures of
cardiac function will include EDV, ESV, LVM, and LVEF. T1 and T2 mapping will also
be implemented that are known to assess cardiac fibrosis and edema. After imaging,
sodium signal ratios, cardiac function parameters, and fibrosis levels will be compared
between sex and age matched hemodialysis patients, chronic kidney disease patients, and
healthy controls.
Chronic kidney disease is known to be a major risk factor for cardiovascular disease,
however, the direct relationship between these diseases remains unclear. It is postulated
that if myocardial sodium content is found to correlate with fibrosis and decreased
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cardiac function, it may be involved in the cardiovascular disease-chronic kidney disease
comorbidity. These results are important as they have the potential to identify a novel site
of sodium storage. Furthermore, they could lead to additional studies investigating
therapeutics that target the myocardium, mobilize the accumulated sodium, and
potentially improve cardiovascular outcomes in chronic kidney disease patients.
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